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ABSTRACT 
 
Transgenic mosquitoes are beneficial for the design and implementation of various 
pathogen control programs. However, low and variable expression of transgenes caused by 
position effects is a hindrance to the characterization and effective use of transgenes in mosquito 
species. The use of insulator sequences to flank transgenes may have the ability to overcome 
position effects caused by the genomic environment surrounding the insertion site. CTCF is a 
multifunctional protein, conserved from humans to Drosophila. Its role as an enhancer blocker in 
the Drosophila bithorax complex and its proximal binding to other insulator proteins on 
Drosophila chromosomes makes it a good candidate for identifying insulator sequences 
throughout the mosquito genome that may be used to improve mosquito transgenesis. Its multi-
functionality as a transcription factor and genome organizer also makes CTCF worthy of 
investigation for an improved understanding of the regulation of the mosquito genome. This 
study uses chromatin immunoprecipitation with an An. gambiae CTCF antibody followed by 
Illumina deep sequencing (ChIP-Seq) to identify regions of CTCF binding throughout the An. 
gambiae genome. A subset of the CTCF binding site peaks was validated using ChIP-PCR. 
Another subset of this data set, including the ChIP-PCR validated peaks, was input into the motif 
finding tool, AlignACE, in order to identify a CTCF binding site consensus. Four motifs were 
identified, none of which were found in more than 11.9% of the ChIP-Seq data set. These results 
lead us to conclude that An. gambiae CTCF binds to a wider variety of sequences compared to 
Drosophila CTCF.  This work also includes a comparison of the expression profiles of the 
dipteran insulator proteins, Su(Hw) and CP190, with that of CTCF across multiple life stages in 
Ae. aegypti. The results of this study suggest the possibility of genomic colocalization, as has 
been recently discovered in Drosophila. The identification of CTCF binding site peaks 
throughout the An. gambiae genome provides a large data set of potential insulator sequences 
that may be used to improve mosquito transgenesis, and provide a new model for the study of 
CTCF function in a species with medical significance. 
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CHAPTER I 
INTRODUCTION 
1.1 The Need for a Solution 
Mosquitoes are responsible for more human death and illness than any other animal on 
the planet. The malaria vector, Anopheles gambiae, is one of the principle species responsible for 
these deaths. As the vector of Plasmodium falciparum, one of the parasites that cause human 
malaria, An. gambiae is one of the principle mosquito vectors responsible for malaria 
transmission on the continent of Africa [1]. This disease is a threat to 3.3 billion people, nearly 
half of the world’s population [2].  Malaria is the cause of 20% of all childhood deaths in Africa. 
An African child is estimated to have between 1.6 and 5.4 episodes of malaria fever per year [2]. 
Pregnant women are also at risk. Not only is death due to complications of the disease a risk; 
spontaneous abortion, premature delivery, and stillbirth are also risks associated with the disease 
[2]. Malaria causes approximately 250 million illnesses per year and nearly one million deaths 
per year. More than 90% of these occur in sub-Saharan Africa [2]. Figure 1 shows the range of 
the three most dominant vectors of malaria in Africa.                                                                                                                          
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Figure 1: Dominant malaria vector species in Africa. This map shows the distribution of the 
three most dominant malaria vector species in Africa. Sinka et al. Parasites & Vectors 2012 [1] 
 
Anopheles gambiae is an efficient transmitter of malaria. It blood feeds almost 
exclusively on humans. The larvae develop in pools of water created by human activities, and 
the adults rest in human dwellings [3]. The degree of adaptation of Anopheles gambiae to 
humans has enabled the Plasmodium parasite to take advantage of the mosquito-human 
relationship to enhance its own parasitic relationship with humans. Anti- malaria drugs such as 
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quinine, chloroquine, Fansidar, mefloquin, and halofantrine have been used to treat malaria 
patients. However, over time, the plasmodium parasite has developed resistance to anti-malarial 
drugs. Currently, artemisinin drugs are the most effective treatments. Artemisinins are combined 
with longer acting malaria drugs for drug therapies known as artemesinin combination therapies 
(ACTs). Although effective, studies have not ruled out adverse reactions being linked to ACTs, 
and further studies are necessary to ensure that these drug therapies are safe [4, 5]. Such 
circumstances emphasize the need to focus the malaria control effort on the mosquito vector. 
Aedes aegypti is the vector of dengue fever and yellow fever. Both of the diseases are 
caused by viruses and no effective treatments are available. Although relatively few deaths occur 
from these diseases, dengue can develop into dengue hemorrhagic fever, a complication that can 
often result in death. There is an effective vaccine for yellow fever, and it can be kept under 
control through vaccine campaigns; however, political instability in some countries results in the 
disruption of the vaccine’s distribution.  This was observed to be the case recently in Cote 
d’Ivoire [6]. On the other hand, no effective vaccine has been developed for the dengue virus, 
and thus this disease can only be controlled through control of the vector mosquito population 
[7]. Both Anopheles gambiae and Aedes aegypti, along with their respective pathogens, are 
currently limited to tropical and subtropical regions. However, it has been estimated that as 
global temperatures increase, the number of people at risk for these diseases will increase by 3-
5% (several hundred million people) [8]. 
1.2 Vector Control 
 The current means of mosquito vector control is insecticide treated bed nets and indoor 
residual spraying. Insecticide treated bed nets successfully repel and control mosquitoes. The 
insecticide treated bed nets are either given to the public or sold at a low cost in order for all 
people to have access to this protection and reduce the rate of disease transmission in endemic 
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areas. Indoor residual spraying is performed for all human dwellings in an endemic area. The 
goal of indoor residual spraying is to end the life of the mosquito before the end of the parasite's 
extrinsic incubation period (10 to 14 days for Plasmodium) [9], so that the Plasmodium parasite 
does not have a chance to develop in the mosquito and infect another human being. Once a 
female mosquito blood feeds on a human host, it becomes lethargic and rests on the walls of the 
human dwelling. This results in exposure to the insecticide, which results in the death of the 
mosquito before it has a chance to transmit mature Plasmodium to another human host. Both of 
these strategies have been effective in controlling vector-borne disease transmission; however, 
both rely on the use of insecticides. Insecticide resistance among mosquito species is rendering 
these strategies ineffective [3]. The distribution of these control methods is also vulnerable to 
civil unrest. Alternative genetic strategies are necessary for effective mosquito vector disease 
control. 
1.3 Genetic Means of Control 
 There are two ways to control the transmission of vector-borne diseases. The first is 
vector population suppression, and the second is vector population replacement [10]. 
Suppression is performed using insecticides, as mentioned above, in addition to alternative 
methods such as the sterile insect technique (SIT) and release of insects with a dominant lethal 
(RIDL). SIT is a method in which males are sterilized, usually via irradiation, and released into 
the wild to mate with wild type females. SIT is well suited for Anopheles mosquitoes because 
females tend to only mate once. Therefore, mating with a sterile male will result in the mating 
female potentially not producing any offspring for its entire lifetime. This approach results in a 
lower vector population and thus lower disease transmission [11]. Disadvantages to this include 
lower fitness of irradiated males, rendering them less effective at mating with the wild females, 
and the difficulty of separating the sterile males from the females.  
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Recently, Oxitech, an Oxford-based research firm has developed an alternative SIT 
strategy. Male mosquitoes are genetically modified in a way such that their offspring are sterile. 
This has the same effect as irradiation; however, genetically modified males and their sterile 
offspring can better compete for mating. Genetically modified males were released beginning in 
November and December of 2009 and followed up with a larger release between May and 
October of 2010. The study showed that the endogenous mosquito population had been 
suppressed by 80% by August 2010 [12]. 
RIDL, the release of insects carrying a dominant lethal, uses a different approach by 
using males carrying a female-specific dominant lethal gene that produces only male offspring, 
resulting in the suppression of the vector population [10, 13, 14]. RIDL uses a transcription 
factor gene under the control of a female-specific promoter or enhancer, which is necessary for 
the transcription of a toxic transgene. Alternatively, a transcription factor can also be used to 
drive the expression of a gene that is only lethal to females. The primary advantage of this 
method is that the effect can carry over into the next generation, as males are fertile. This method 
also eliminates the need to raise and eliminate females from a sterile insect strain and has the 
advantage of using transgenic males, which have a fitness advantage over irradiated males [15].  
For both methods, it is important that only males be released, as females could 
contribute to an unwanted increase in mosquito populations, reduce the efficacy of the trial by 
mating with sterile males, and transmit disease. Although RIDL eliminates females before 
release, most systems do not eliminate them until the adult stage resulting in the extra cost of 
raising unwanted females up to this life stage. In the earlier part of the last decade, transgenic 
tagging systems were developed such that fluorescent transgenes that were only expressed in the 
testes could be used to sort males from females using a flow cytometer. This system was limited 
by the fact that the fluorescence could only be detected at the late larval stage. Recently this 
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system has been enhanced such that early sex-specific transgenic markers can be detected at 
early stages of development of Anopheles gambiae mosquitoes. Larval populations can be sorted 
by sex, transgenic/non-transgenic, heterozygous/homozygous, transgenic females/non-transgenic 
males. The system also has no effect on the mating ability of the adult males, thus improving the 
productivity of population suppression systems [11]. 
Population replacement is based on a strategy using transgenic mosquitoes that are 
resistant to the vector-borne disease to replace the current mosquito population [10]. This avenue 
of vector control shows some promise with several advances having been made in recent years 
[16]. The use of transposable elements for inserting transgenes into mosquito genomes has been 
successfully pursued. Six mosquito species, Aedes aegypti, Aedes fluviatilis, Anopheles 
albimanus, Anopheles gambiae, Anopheles stephensi, and Culex quinquefasciatus, have all been 
genetically transformed with transposons carrying  transgenes [16]. Some of these transgenes, 
such as [SM1]4, PLA2, and Cecropin A have conferred some level of Plasmodium resistance to 
the transformed mosquito species[16]. Transgenesis using dsRNA constructs may be used to 
silence genes necessary for Plasmodium transmission. An Ae. aegypti strain expressing dsRNA 
targeting REL1, an innate immune response gene, experienced REL1 inhibition [16], 
demonstrating the potential of this approach. 
 Paratransgenesis, the use of genetically modified symbionts to reduce vector 
competence, also shows possibilities for disease transmission control. Asaia sp. bacteria have 
been successfully transformed with enhanced green fluorescent protein (EGFP) expressing 
plasmids and introduced to adult mosquitoes through a sugar or blood meal resulting in 
infection. Larvae were also able to be infected with the bacteria from their aquatic environment 
[16]. Asaia are found in the mosquito midgut and salivary glands, which are the sites of pathogen 
development and transmission. The bacteria are also transmitted from male to female during 
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mating and then transmitted vertically to the offspring[16]. To demonstrate the proof of 
principle, Escherechia coli expressing the anti-malaria molecules SM1 and PLA2 were able to 
inhibit P. berghei development in An. Stephensi [16]. 
 Even with all of the recent success in mosquito transgenesis, many challenges remain. 
Blockage of Plasmodium infection through mosquito transgenesis has not yet been achieved for 
human parasites [16]. To date, mosquito transgenesis has only been shown to block P. berghei, 
the rodent parasite and one of these cases was in a non-natural mosquito-parasite pair, An. 
stephensi-P. berghei. The one successful demonstration of a transgenic insect impairing the 
development of a human pathogen is a transgenic strain of Ae. Aegypti, which inhibits the 
dengue virus  development [16]. The relative fitness of transgenic mosquito populations has also 
been an issue. As mentioned above in regard to SIT, a less fit transgenic population would be 
unable to drive the transgene through the natural population. Although it was shown that An. 
stephensi mosquitoes hemizygous for the SM1 transgene exhibited higher fitness than wild type 
mosquitoes when fed on P. berghei infected mice, mosquitoes that were homozygous for the 
SM1 transgene, exhibited lower fitness [16].  
On a more optimistic note, transgenic An. stephensi mosquitoes generated with the 
ΦC31 integrase system, expressing a fluorescent marker gene, showed no significant difference 
in fitness when compared with wild type mosquitoes [17]. This provides an integration system 
that may be useful for effective mosquito transgenesis. This is particularly helpful in controlling 
position effects as the attP docking site provided by the ΦC31 integrase system allows for site 
specific integration into the genome [18]. This results in the transgene integrating at the same 
position in every transgenic line, thus avoiding variable expression levels due to position effects 
caused by random integration of transposable elements. 
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 Other problems exist in relation to using transposons to insert transgenes into insect 
genomes. Non-canonical transposition reactions can result in integration of donor plasmid 
fragments throughout the insect genome. Transgene size can influence transposon activity. 
Transposons may also remobilize into somatic tissues and cause damage in some regions of the 
genome [16]. A serious ecological problem may also result in the event of horizontal transfer of 
the transgene to a sibling or non-related species [16]. Another problem with the use of 
transposons for transgene integration is the variable expression of transgenes due to random 
integration into the genome that results from the cut and paste transposase system. Random 
integration results in both position effects (PE) and position effect variegation (PEV). Position 
effects are the result of a transgene being affected by regulating elements near the insertion site. 
For example, insertion of the transgene near an enhancer may result in over expression; insertion 
near a silencer may result in reduced or no expression. Position effects result in various 
expression levels between transgenic lines due to varying chromosomal environments at each 
insertion site. Position effect variegation is the result of repression of transgene expression due to 
heterochromatin spreading at the insertion site, leading to silencing of the transgene. The amount 
of heterochromatin spreading at each genomic location is variable between different cells and 
tissues within the organism; therefore, PEV causes variable expression of the transgene within a 
transgenic line. These two issues are of concern for many applications of mosquito transgenesis. 
 Examples of position effects have occurred in transgenic lines of Ae. aegypti involving 
two different transposable elements. In two separate studies, the Hermes and Mariner elements 
were used to insert the D. melanogaster wildtype cinnabar gene (cn+) into the Ae. aegypti 
genome. All transformed mosquitoes were mutants for the sex-linked white gene khw; therefore 
colored eyes in subsequent generations indicated insertion of the gene [19]. In the Hermes study, 
four founder families and one pool produced G1 progeny with colored eyes with varying eye 
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color from light to dark red. In the Mariner study, five founder families produced G1 progeny 
with colored eyes. Eye color varied between families ranging from a light orange to 
purple/black. These results indicate that the different positional insertions across these families 
resulted in different levels of transgene expression due to different chromosomal environments. 
One family from each study had progeny with varying eye color among them. Such results 
suggest position effect variegation due to the variation in gene expression among individuals 
with a common insertion site [20, 21]. 
Benedict [22] identified a PEV phenotype in An. gambiae in a cross of pink eye (p) 
females with irradiated males. This variegated phenotype consists of patches of wild-type 
ommatidia over a pale pink background. This phenotype was named Mosaic (Mos). Genetic 
studies confirmed that Mos was sex linked, and suggested that recombination occurs between 
Mos and pink eye (p). The estimated distance between the two was 14.4 cM. Crosses were also 
conducted to determine if Mos would be expressed in a white mutant background. The crosses 
revealed that w is epistatic over Mos. Cytogenetic analysis of ovarian nurse-cell polytene 
chromosomes of Mos/Mos+ and Mos/Mos females revealed an insertion of euchromatin into the 
heterochromatic region of division 6 on chromosome X. Based on the genetic analysis, it was 
suspected that a wild type pink eye (p+) duplication might be involved in the insertion. The 
region of the chromosome at which pink eye is located, 2B, was compared to the euchromatic 
insertion at division 6 and the cytological appearance was similar. To confirm that the insertion 
was indeed a p+ duplication, two mapped cDNAs of the 2B region, c51 and c81, were hybridized 
independently to ovarian polytene chromosomes of Mos homozygotes. Indeed, c51 consistently 
hybridized to the insertion and 2B, confirming that the insertion was a duplication of pink eye 
[22]. Benedict[22] believes that this insertion was the result of a transposition event in which p+ 
was inserted into the heterochromatic region of division 6 on chromosome X, thus deleting the 
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p+ allele such that it would not compliment the pink eye mutation on its homologue. The new 
position of the p+ allele resulted in a PEV phenotype. 
1.4 The Natures of the Mosquito Genomes 
 The genomes of An. gambiae and Ae. aegypti are quite different from that of Drosophila 
melanogaster, in which the majority of insect genome studies have been performed. The genome 
sizes among the three vary substantially in size with An. gambiae having two-fold the genome 
size at 272.8 Mb compared to 118 Mb for Drosophila [23]. The Ae. aegypti  genome is 5 times 
larger than that of An. gambiae at 1,376Mb [23].  Aedes aegypti has nine times the average 
length of intergenic region compared to Drosophila (six times compared to An. gambiae) and 
four times the average intron length in Drosophila (three times compared to An. gambiae) [23]. 
Some of these differences are due to loss of non-coding DNA from the D. melanogaster genome. 
This is supported by the fact that all Anopheles species have genome sizes between 240Mb and 
290Mb  and all other culicids have genomes of 500 Mb or greater, and all except  two 
Drosophilid species have genome sizes of 230Mb or greater [3]. The number of coding genes, 
exons, and coding lengths vary by less than 20% between Drosophila and Anopheles [2]. The 
variation in genome size is likely due to the loss of non-coding DNA sequence from D. 
melanogaster and the insertion of transposable elements throughout the two mosquito genomes 
over evolutionary time [3, 23, 24]. 
 The An. gambiae genome has approximately 40 different identified types of transposons. 
Most of these are Class I repeats; particularly long terminal repeat retrotransposons (LTRs), 
small interspersed nuclear elements (SINEs), and miniature inverted repeat transposable 
elements (MITEs). All of the major Class II transposon families are also represented [3]. 
Transposon densities differ according to the chromosomal arm. The X chromosome has the 
highest transposon density with 59 transposons per Mb. Chromosomal arms 2R, 2L, 3R, and 3L 
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have 37, 46, 47, and 48 transposons per Mb respectively. The large number of paracentric 
inversions on chromosomal arm 2R may be related to its lower density of transposable elements 
as recombination is more frequent in regions where transposon density is lower [3]. Transposons 
make up approximately 16% of the genome’s euchromatin and 60% of its heterochromatin, 
compared to 2% and 8%, respectively of the D. melanogaster genome. Transposons present in 
heterochromatin are highly fragmented; therefore, 60% is likely an underestimate. It has been 
noted that there must be a mechanism within the heterochromatin that promotes transposon loss 
from these regions in order to balance the insertion of new copies [3]. 
The An. gambiae and D. melanogaster genomes have 12,981 one-to-one orthologs and 
1,779 many-to many-orthologs [24]. This supports the notion that most of the differences in 
genome sequence are due to intergenic non-coding DNA as mentioned above. In addition to 
intergenic regions, introns are also important in accounting for this difference, as well as some 
genes unique to mosquito biology.   
A comparison of protein coding genes between Ae. aegypti, An. gambiae, and D. 
melanogaster show that the mosquito species have a significant number of unique genes shared 
exclusively between them. This demonstrates the unique biology shared exclusively among 
mosquitoes. Comparison of orthologs among these three species reveals that 67% of the Ae. 
aegypti proteins have an ortholog in the An. gambiae genome, with only 58% having an ortholog 
in the D. melanogaster genome [23]. Comparison of three way single copy orthologs showed 
74% average amino acid identity between the mosquito species compared to 58% identity 
between mosquito and fruit fly. Approximately 2,000 orthologs are shared only between the two 
mosquito species, possibly representing functions unique to mosquito biology [23]. It seems 
likely that the mosquito’s hematophagy would contribute to the difference in coding genes 
compared to Drosophila. Interestingly, only one gene family, the peroxidases, demonstrates 
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major differences in gene copy numbers between An. gambiae and D. melanogaster. Preliminary 
analysis indicates that peroxidases are important during the invasion of the midgut by malaria 
parasites [24]. Peroxidases have also been linked to blood feeding [25]. 
 Genome organization is varied greatly between Anopheles and Drosophila such that 
only small gene neighborhoods have been retained. This is known as microsynteny [24]. 
Numerous local inversions, translocations and gene duplications have resulted in two very 
different genomes. Such events may have led to the loss of non-coding DNA from the 
Drosophila genome as well as to the relatively rapid evolution of this non-coding DNA, thus 
leading to the divergence in genome structure.  Insertion of transposable elements is also likely 
to have led to this divergence. Overall, 4,099 Anopheles genes and 4,244 Drosophila genes are 
assigned to 948 confirmed microsynteny blocks. The fraction of orthologs that remain within 
mircrosynteny blocks determined to exist between these two species is 34% in Anopheles. This 
figure represents a significant amount of local neighborhood conservation between Anopheles 
and Drosophila; however, it is considerably lower than the corresponding fraction (40%-50%) 
between puffer fish and mammals [24]. This highlights the much higher rate of insect evolution 
compared to vertebrates. 
 The most conserved pair of chromosomal arms between An. gambiae and D. 
melanogaster is Dm2L and Ag3R, with 95% of microsynteny blocks in Dm2L mapping to Ag3R. 
The remaining 5% represent exchanges with other arms which fail to have a significant signal 
above random expectation [24]. The chromosomal arm Ag3R microsynteny also maps 
significantly to Dm2L at 83%. Dual correspondence is detected in other arms, with one arm of a 
species corresponding with two arms of the other. For example, the Anopheles 2L arm contains 
approximately 42% and 54% of the contents of the Drosophila 2R and 3L arms, respectively 
[24].  This further illustrates the genomic rearrangement that has occurred between these two 
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species over evolutionary time. The loss of non-coding DNA in D. melanogaster and the lower 
number of transposon insertions are likely to have led it to have a much more condensed genome 
with most of its heterochromatin localized to the centromeres and telomeres in comparison to 
An. gambiae, resulting in a smaller number of blocks of euchromatin.. As mentioned previously, 
the difference in genome size between Drosophila and Anopheles is likely due to differences in 
intergenic DNA sequence due to a higher number of transposable element insertions into the An. 
gambiae genome. The presence of interstitial blocks of heterochromatin along euchromatic 
chromosome arms leads to the possibility of stretches of intergenic heterochromatin flanking 
active euchromatic genes, or legitimate gene repression is carried out by blocks of intercalary 
heterochromatin.  Alternatively, some of the Anopheles genes may have adapted to being 
expressed in heterochromatin, similar to the Drosophila gene, light. 
The amount of repetitive sequence and high amount of genetic variation within both of 
the above mentioned mosquito genomes have caused much difficulty in assembling them. 
Although most of the An. gambiae gene sequence has been mapped to chromosomes, a number 
of unassembled chromosome fragments are classified as unknown. Also, the repetitiveness of the 
An. gambiae genome makes analysis of intergenic regions difficult. The Ae. Aegypti genome 
sequence is yet to be mapped to chromosomes due to the large number of repeats that have 
hindered its assembly. The Ae. aegypti Liverpool strain genome is organized into contigs, 
sequences that have been mapped together to form long stretches of assembled sequence. The 
1.3 Gb genome is organized into 4,758 supercontigs. The average length of these supercontigs is 
1500 kb. Smaller assembled sequences are known as contigs and have a length of 82 kb [26]. 
Although supercontigs are helpful for knowing where many sequences are in relation to many 
other sequences on a single contig, the gaps between contigs make effective study of the whole 
genome problematic. Such features have hampered genomic analysis, eliminating such tools as 
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microarrays with sufficient coverage of the genome to analyze gene regulatory regions, which 
have been quite useful in Drosophila.  
1.5 Chromatin Maintenance and Regulation 
 Eukaryotic genomes are organized into domains of active and silenced chromatin. These 
chromatin domains can be defined differently; either as actively transcribed versus inactive 
chromatin domains, as DNase I-sensitive versus DNase I–resistant chromatin domains, or by the 
distribution of specific histone variants.  Active domains tend to have a higher concentration of 
acetylated core histones as well as histone H3 methylated at lysine 4 (H3K4) [27]. Silent 
domains tend to have a higher concentration of histone H3 methylated at lysine 9 (H3K9) and 
histone H3 methylated at lysine 27 (H3K27). Active and silenced domains can be referred to as 
euchromatin and heterochromatin respectively. These are defined cytologically with the tightly 
condensed dark bands of chromosomes referred to as heterochromatin and the clear interbands 
referred to as euchromatin.  
Two types of heterochromatin exist in eukaryotic organisms. Constitutive 
heterochromatin is the chromatin that remains silent in almost all cell types and primarily resides 
at the centromeres and telomeres of chromosomes. Constitutive Intercalary heterochromatin may 
also be present throughout the chromosome arms. Facultative heterochromatin refers to regions 
of euchromatin that are silenced during cellular development [27]. The genomic regions of 
facultative heterochromatin vary from cell type to cell type, and play an important role in cell 
differentiation. An example of the function of facultative heterochromatin is X chromosome 
inactivation in female mammals. 
Heterochromatin is tightly condensed, resistant to crossing over, late replicating and is 
unable to be transcribed in most cases, although exceptions do exist [27]. It is believed that 
heterochromatin is important for gene regulation [28]. Models for heterochromatin formation 
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and spreading are based on experiments in fission yeast, Drosophila, and mammals. The 
generation of double-stranded RNA is required for initiation of pericentric heterochromatin 
nucleation. The double-stranded RNA is processed by the RNAi mechanism into small 
interfering RNAs (siRNA) [27, 29]. The siRNAs are necessary to target proteins necessary for 
heterochromatin formation to the centromere. It has been shown that deletion of RNAi 
machinery such as ago1, dcr1, and rdp1 is correlated with loss of pericentric heterochromatin 
and transcription of pericentric reporter genes [29, 30]. Transcription of repetitive sequences at 
the centromeres leads to recruitment of RNAi machinery and accumulation of siRNAs. This 
accumulation of siRNAs results in recruitment of histone modifying proteins such as Rpd3, 
Hda1, Su(var3-9) and HP1. These proteins form heterochromatin by deacetylating, methylating, 
and binding to Histone H3 at lysine 9 (H3K9) [29, 30]. HP1 then assembles nucleosomes into 
heterochromatin, and helps it spread by recruiting RNAi machinery and HDACs to continue the 
process bidirectionally. [29, 31].             
Gene silencing in intercalary heterochromatin is independent of H3K9 methylation. In 
some regions, methylated H3K27 and polycomb-group proteins govern the silencing process. 
Intercalary heterochromatin is composed of unique sequences, including transposons in some 
cases. Intercalary heterochromatin is generally the sum of multiple silenced genes in close 
proximity to one another, with synchrony in replication, resulting in a visible band of 
heterochromatin. Such groups of genes in Drosophila include the homeotic genes, which are 
regulated throughout development. These sequences include a Polycomb response element 
(PRE), which recruits Polycomb group proteins [32, 33]. This recruitment is mediated by HMT 
(EZ), which catalyzes H3K27 methylation.  A Polycomb protein complex binds to H3K27me2/3 
via its chromodomain, similar to the manner in which HP1 binds to H3K9me2/3. The polycomb 
proteins interact with transcription initiation proteins to maintain repression of transcription [34]. 
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Pericentric and intercalary heterochromatin are necessary for regulation of the genome. 
Pericentric heterochromatin is necessary for establishment of the centromere in order to maintain 
chromosomal segregation.  Intercalary heterochromatin is necessary to restrict the expression of 
specific genes to specific tissues throughout the development and life of the organism. 
The maintenance of heterochromatin/euchromatin boundaries is also important for 
proper gene regulation. Studies of cHS4, a complex vertebrate insulator located at the extreme 5’ 
end of the chicken β-globin locus, support a model for a molecular mechanism that blocks the 
spread of heterochromatin. An insulator is a DNA sequence that regulates gene expression. The 
barrier function at cHS4 is established by the sequence-specific DNA-binding proteins upstream 
transcription factor 1 (USF1) and USF2. These two proteins recruit histone acetyl transferases 
and histone methyl transferases, which lead to cHS4 mediated acetylation and H3K4 methylation 
of nucleosomes. Mutations of cHS4 that disrupt the binding of USF1 and USF2 eliminate 
recruitment of HATs and HMTs and abolish barrier activity at cHS4. This led to the proposal 
that acetylation and H3K4 methylation of nucleosomes renders them resistant to H3K9 
methylation and HP1 binding, thus stopping the spread of heterochromatin. Similar mechanisms 
may be based on other heterochromatin histone modifications. [35] 
The formation and maintenance of active chromatin is necessary for gene transcription 
and is an active process. Specific DNA elements are required to recruit chromatin remodeling 
and modifying enzymes to open the domain so that enhancers can communicate with promoters. 
Factors necessary for activating chromatin vary from one locus to another [27]. The activation of 
chromatin is necessary for gene transcription; however, chromatin activation does not guarantee 
gene transcription. The presence of specific transcription factors may be necessary for 
transcription of a particular gene to occur. Once a chromatin domain is activated, an enhancer 
sequence is able to communicate with the promoter(s) of the gene(s) it regulates. Considering 
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that enhancers may be on the order of 100 kb upstream or downstream of the gene(s) they 
regulate, the manner in which communication occurs is of much interest. Some models suggest 
looping of the intermediate chromatin, while others suggest the tracking of recruited activator 
proteins along the chromatin fiber to the promoter region where it interacts with the transcription 
initiation complex.  Another, known as the hopping model, involves the random sampling of an 
enhancer bound activator along the intervening chromatin until it encounters the target promoter 
[27]. Figure 2 illustrates these three models of gene activation. The formation of transcription 
factories is another version of chromatin looping in which an enhancer sequence, such as a locus 
control region (LCR), recruits multiple promoters and the necessary transcription machinery to 
facilitate the transcription of multiple genes [36]. 
 
 
A   B     C  
Figure 2: Three models for enhancer-promoter interaction for gene activation. A) The 
tracking model suggests that once the transcription machinery (maroon oval) is recruited to the 
enhancer sequence (red) it travels the length of the sequence until it reaches the promoter 
sequence (green) at which point transcription can be initiated. B) The hopping model suggests 
that once the transcription machinery is recruited to the Enhancer, it samples the intervening 
sequence (purple and orange lines represent unsuccessful sampling attempts) until it makes 
contact with the appropriate promoter sequence. C) The looping model suggests that the 
enhancer sequence directly recruits the transcription machinery to the promoter sequence. 
 
 
 
Active domains allow for the communication of enhancers with promoters. Given that 
enhancers can interact with multiple promoters, the need arises for regulation of this interaction 
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to control appropriate gene expression throughout the genome. One of the ways this is facilitated 
is through the partitioning of the genome into active and inactive domains. This partitioning of 
the genome maintains the expression of genes in one active domain to be controlled only by the 
enhancers of that domain. Gene expression within the genome may also need to be regulated 
within an active chromatin domain. This calls for the need of an enhancer blocker. This concept 
is illustrated at the human Igf2/H19 locus at which an insulator sequence regulates the 
expression of these two genes. H19 is paternally imprinted and Igf2 is maternally imprinted. In 
this case, the two genes share enhancers that are located downstream of the two genes. The 
imprinting of one of the two genes is determined by differential methylation patterns of the 
parent of origin. At the paternal locus, a region downstream of Igf2 and upstream of H19 is 
differentially methylated, thus blocking the binding of CTCF, an insulator binding protein. This 
allows for the enhancer to communicate with Igf2 and bypass the methylated H19 promoter, thus 
Igf2 is expressed and H19 is imprinted. At the maternal locus, this differentially methylated 
region is not methylated, allowing for the binding of CTCF which inhibits the communication of 
the enhancers with the Igf2 promoter and allows interaction with the H19 promoter. Thus the 
binding of CTCF to the differentially methylated domain acts as an enhancer blocker at the 
maternal locus[37]. Enhancer blocking is an important regulatory function throughout the 
genome, and is one of the two functions of insulators. 
As mentioned above, an insulator is a DNA sequence that regulates the genome by 
neutrally regulating gene expression. It neither specifically silences nor activates genes. Its 
function is to regulate the influence of silencing and activating elements through enhancer 
blocking and/or maintaining a barrier between euchromatin and heterochromatin. The example 
above illustrates the enhancer blocking function of an insulator. Another example of an insulator 
acting as an enhancer blocker is the case of an insulator discovered on the 3’ end of the 
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Drosophila white gene, known as white abutting resident insulator (Wari) [38]. Multiple 
transgenic experiments were performed to characterize the enhancer blocking function of this 
insulator sequence. The results of these experiments are summarized in Table 1. Chetverina et al. 
[38] began by excising the insulator sequence and inserting it between the eye enhancer and the 
mini-white gene. This reduced expression of mini-white. Excision of the insulator sequence from 
this position restored mini-white expression as expected. They also performed a similar 
experiment with a different construct in which yellow preceded white and the insulator was 
placed downstream of the wing, eye, and body enhancers and upstream of white and yellow.  The 
expression of yellow and white were reduced, showing that the insulator was not specific to the 
mini-white gene. When the insulator was placed upstream of the enhancers such that it was no 
longer between the enhancers and the two reporter genes, there was no effect on the expression 
of either gene. Insertion of the insulator in an intron of the yellow gene resulted in white 
experiencing weakened expression, while yellow was unaffected. These experiments show that 
the function of this insulator is position dependent [38].  
 Assays also showed that a pair of Wari sequences, flanking the yellow and white gene 
sequences, decreased gene expression for both reporter genes even more so than a single Wari 
sequence positioned between the enhancers and gene promoters. Other assays showed that if the 
second insulator sequence was placed between the yellow and white genes, only the gene 
sequence flanked by the two insulators will have reduced expression. These results are 
summarized in Table 1. If yellow was flanked by the two insulators, only yellow had reduced 
expression, leaving white unaffected or with increased expression. Chetverina et al. [38] deduced 
that the interaction between the two insulators, resulting in the looping out of the yellow gene, 
would thus result in its insulation from the enhancer and its decrease in expression.  This looping 
due to insulator interaction results in the enhancer bypassing the insulators and the activation of 
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the mini-white gene. The looping would also result in decreasing the distance between the eye 
enhancer and the mini-white gene, thus increasing the expression of mini-white [38]. 
Due to their ability to block interactions of enhancers and silencers with promoters, as 
well as block the spread of heterochromatin, it has been proposed that flanking a transgene with 
insulators will ameliorate the problem of position effects [39]. Site specific integration has also 
been proposed to solve this problem; however, predetermined integration sites are not always 
optimal for sufficiently high levels of transgene expression [39]. The ΦC31 integrase system 
integrates transgene containing plasmids with attB sites at attP landing sites within the genome. 
However, the attP landing sites are randomly integrated into the genome. Therefore, position 
effects can still affect the expression of the transgene [39]. It has been shown that position 
effects vary greatly from one tissue to another at any attP site in Drosophila [39]. However, 
Markstein et al. (2008) [39] have shown that flanking the transgene with the gypsy insulator 
results in significantly increased gene expression at three different attP sites compared to the un-
insulated loci (Figure 3) [39]. This provided the opportunity to create transgenes at a single locus 
that can be highly expressed in most, if not all, tissues in Drosophila [39] . The use of insulators 
in conjunction with ΦC31 sites may provide the same opportunity for An. gambiae and other 
mosquito species. 
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Table 1: Effects of the WARI insulator on yellow and white expression. Construct maps from 
Chetverina et al. show orientation of the Wari insulator in relation to wing, body, and eye 
enhancers (W, E, B) and yellow and white. The box containing 825 in the first four diagrams 
refers to an 825 bp sequence containing the Wari insulator. Reduced or Increased refers to 
expression levels with reference to wild type expression. Images from Chetverina et al.(2008) 
[38]. 
Construct Map yellow 
expression 
white expression 
 
 
 
N/A 
 
Reduced 
 
 
 
Reduced 
 
Reduced 
 
 
 
Wild Type 
 
Wild Type 
 
 
 
Wild Type 
 
Reduced 
 
 
 
Reduced 
 
Reduced 
 
 
 
Reduced 
 
Wild Type or 
Increased 
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Figure 3: Luciferase activity from insulated and uninsulated transgenes.  Luciferase activity 
from the un-insulated (left) and insulated (right) (ovals represent gypsy insulator sequences) 
induced UAS::Luciferase transgene induced in larval muscle, larval fat body, larval imaginal 
discs, and larval ubiquitous. (Markstein et al. (2008) [33]) 
 
1.6 CTCF as an Insulator Protein 
 CTCF is the only known insulator protein in vertebrates. It is a zinc finger protein, 
which is also known to act as an activator, a repressor, and a chromatin organizer. It is important 
for cell functions such as growth, proliferation, differentiation, apoptosis, nucleosome 
positioning, X-chromosome inactivation, cell cycle regulation and imprinting [40, 41]. CTCF 
has been described as a genome organizer which binds to multiple sequences throughout the 
genome, which, along with chromatin context, dictate the function of CTCF at each binding site 
[42]. CTCF is also found in insects and has been shown to play a role in insulator function [43]. 
Therefore, we see CTCF as an important factor for regulation of the An. gambiae genome, which 
deserves further study for the purposes of understanding An. gambiae gene regulation and 
identifying binding sequences that could be used to improve An. gambiae transgenesis.  
CTCF has been shown to bind at important insulators in the bithorax complex of D. 
melanogaster. However, other insulator proteins such as Su(Hw), BEAF-32, Zw5, GAGA factor, 
MOD(MDG4) and CP190 also exist in insects. The presence of multiple insulator proteins in 
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insects, specifically dipterans, implies a need for a variety of insulator proteins in insect 
genomes. How the presence of additional insulator proteins affects the role of CTCF in insects as 
compared to its role in vertebrates is yet to be elucidated; however, Drosophila ChIP-Seq data 
show that CTCF, Su(Hw), BEAF-32, MOD(MDG4), and CP190 bind in tandem at many 
genomic locations suggesting a synergistic relationship among these proteins for insulating 
activity [44]. 
 CTCF has been shown to be necessary for the function of the Frontal abdominal 8 (Fab- 
8) insulator in the bithorax complex (BX-C) of Drosophila between iab 7 and iab 8 [43]. CTCF 
binding to Fab 8 was confirmed by a methylation interference assay. Mobility shift assays with 
negative control or mutant CTCF binding site sequences and wild type sequences revealed that 
the wild type sequences were retarded by protein binding and the mutated sequences and 
negative control sequences were not, showing that the Fab 8 sequence is necessary for the 
binding of CTCF at the Fab 8 insulator [43, 45]. Chromatin immunoprecipitation assays in 
conjunction with PCR using primers flanking the Fab 8 sequence and sequences not shown to 
bind to CTCF revealed that CTCF binding was unique to Fab 8 [43, 45]. Enhancer blocking 
assays have also confirmed the role of Fab 8 as an insulator when binding CTCF [43]. 
Experiments with mutated CTCF binding sites in the Fab 8 sequence incorporated into an EGFP 
reporter gene construct transfected into stable S2 cell lines, as well as a CTCF knockdown using 
RNAi in stable S2 cell lines with a similar EGFP reporter gene construct containing wild type 
Fab 8 insulators showed that CTCF is necessary for the function of the Fab 8 insulator [46]. 
Smith et al. found that CTCF tends to bind near the promoters of genes and between 
gene promoters that are transcribed in opposite directions and those that are spatially or 
temporally divergent [47]. ChIP-on-chip data showed that CTCF binds between the Drosophila 
ortholog of the human gene implicated in Alzheimer’s disease, β amyloid protein precursor-like 
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(Appl) and an uncharacterized transcript CG4293. Affymatrix expression data shows that Appl is 
expressed in the embryo 6 hours into development and that CG4293 is likely maternally loaded 
and is transcribed early in embryogenesis. The ChIP-on-chip data shows a strong CTCF peak 
between the two divergently transcribed promoters. An example of spatially divergent genes 
separated by CTCF is the case of the divergently transcribed bicoid (bcd) and Amalgam (Ama) 
genes. bcd is restricted to the anterior of the early embryo, whereas Ama is expressed in 
embryogenesis and is localized in the dorsal region and neural ectoderm of the embryo. Such 
CTCF binding patterns suggest that CTCF may be necessary for the differential regulation of 
closely positioned genes [47]. 
 The experiments described above apply specifically to the enhancer blocking insulator 
function of dCTCF in Drosophila. Experiments in vertebrates show that CTCF also plays an 
important role as a chromatin barrier. The human tumor suppressor gene,  p16INK4(p16), is 
flanked by heterochromatin borders from approximately 2kb upstream of the transcription start 
site to approximately 1kb to 4kb downstream of the transcription start site. In breast cancer cells 
with aberrantly silenced p16 genes, these heterochromatin borders are absent [48]. Examination 
of the sequence 3’ of the heterochromatin border revealed the presence of a CTCF binding site. 
CTCF was observed to be associated with this region in p16 expressing cell lines, yet not in p16 
non-expressing cell lines [48]. Chromatin immunoprecipitation analysis revealed that in p16 
expressing cells, CTCF clearly binds downstream of heterochromatin in the p16 promoter 
region. No CTCF binding occurred near -7 Kb or +4 Kb in relation to the p16 transcription start 
site. Interestingly, although CTCF is not present at this region in p16 non-expressing cells, it is 
present at other genes such as c-myc [48]. 
 Knock-down of CTCF with shRNA was performed in p16 expressing cells to observe its 
effects on p16. The mRNA levels of p16 as well as H19 were reduced. However, c-myc 
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remained impervious to the loss of CTCF, suggesting a different function for CTCF at this locus. 
H2A.Z was absent from the p16 promoter and a 3’ shift of H4K20 also occurred. Transcription 
of p16 could be restored with the drug, AZA; however, AZA does not restore CTCF binding 
[48]. 
 Orthologs for CTCF have been identified in Anopheles gambiae and Aedes aegypti [49]. 
These orthologs have 38% identity and 56% similarity with D. melanogaster and H. sapiens 
across all eleven zinc finger domains, respectively, and 68% of the critical binding residues are 
conserved. The expression of the two mosquito CTCF proteins span across all life stages with 
increased expression in the embryo and ovary of the blood fed female, which is consistent with 
its potential role as an insulator protein at important developmental stages [50]. They are also 
believed to be bound to nuclear structures and expressed in ovarian nurse cells [49, 50]. CTCF 
Immunostained chromosome spreads have revealed a low resolution distribution of CTCF 
binding along the chromosomes of Anopheles gambiae ovarian nurse cells. This work identifies 
regions of CTCF binding in the Anopheles gambiae genome at a higher resolution through the 
ChIP-Seq technique. The expression profiles of Aedes aegypti cp190 and su(Hw) were also 
determined and examined in the attempt to initiate further work that may lead to the 
identification of yet more effective insulator sequences that could be used for the improvement 
of mosquito transgenesis by overcoming the challenges of Position Effects and Position Effect 
Variegation. 
 The prospect of this work is that the identification of CTCF binding regions will provide 
another resource for genetic engineers to establish more reliable lines of transgenic mosquitoes 
which could be used for disease vector suppression or replacement. Insulator sequences could be 
incorporated into a transgene construct, flanking the transgene in order to insulate it from 
elements causing PE and PEV. If known CTCF binding sites prove to be effective insulators, 
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mosquito strains could be developed with фC31 attP docking sites flanked with CTCF binding 
sites by randomly inserting attP фC31 docking sites with flanking CTCF binding sites at 
multiple genomic locations via an effective transposable element. This would create strains of 
mosquitoes that could be transformed using site specific insertions that are insulated at every 
site.   
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CHAPTER II 
IDENTIFICATION OF REGIONS OF CTCF BINDING IN THE Anopheles gambiae 
GENOME 
2.1 Introduction 
 The zinc finger protein, CTCF, has been shown to be associated with repressor, 
activator, and an insulator functions in human, chicken, mouse, and D. melanogaster [42, 51].  
The insulator property can be divided into two functions: enhancer blocking and heterochromatin 
barrier. As explained in Chapter I, an insulator would be advantageous for the production of 
transgenic mosquito strains by incorporating CTCF binding site sequences into a transgene 
construct, such that a transgene would be insulated from genomic elements that may cause 
position effects or position effect variegation. An understanding of the potential activator and 
repressor functions of mosquito CTCF will enhance the understanding of individual gene and 
genome wide transcriptional regulation, in disease vector species such as An. gambiae. CTCF is 
known to bind to a variety of DNA sequences [42, 51] . It has been proposed that this is the 
result of the use of different subsets of zinc fingers to bind to each DNA sequence. Ohlsson et al. 
(2010) [42] has proposed that the binding of a particular set of the zinc fingers results in a 
particular function; with the function of CTCF being determined by the DNA sequence at the 
binding site[42].  
The first step in understanding the multiple roles CTCF plays in regulating An. gambiae 
gene expression is the identification of CTCF binding sites throughout the genome. The 
discovery of a functional insulator sequence has the potential to provide insulating sequences for 
transgene constructs that would maintain stable expression of refractory transgenes that block 
malaria transmission. In addition to this primary purpose, identification of CTCF binding 
sequences proximal to genes and gene clusters will facilitate further opportunities for the study 
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of mosquito gene regulation. The identification of a CTCF binding site map will guide future 
studies of gene regulation and CTCF function. 
 Identifying transcription factor binding sites in the An. gambiae genome is an ambitious 
task. To date, the primary tool for identifying global transcription factor binding sites has been 
Chromatin Immunoprecipitation (ChIP) of transcription factor bound DNA, followed by 
hybridization to a microarray of known DNA sequences covering much of the subject genome. 
This technique, also referred to as ChIP-on-chip, has been used to identify CTCF binding sites 
throughout the Drosophila melanogaster genome [45, 52]. Genomic DNA microarrays for An. 
gambiae are available; however, regulatory regions are not well represented. Impetus for the 
development of a microarray that includes the intergenic sequences necessary for the global 
analysis of transcriptional regulation has been lacking due to the challenges of obtaining 
sufficient DNA oligonucleotides from the incompletely sequenced genome, as well as the 
relatively limited number of researchers that would find use for such an array. 
In recent years, the advent of next generation sequencing has provided a means for wider 
coverage of the genome. Chromatin Immunoprecipitation followed by parallel sequencing 
(ChIP-Seq) allows for a significant number of the immunoprecipitated DNA fragments to be 
sequenced in parallel. This approach also eliminates the bias associated with hybridization to a 
microarray with a limited number of sequences. ChIP-Seq provides an increased base pair 
resolution, suffers from less noise, provides greater coverage, and has the ability to capture 
heterochromatin and microsatellites, which are abundant in this genome and may include regions 
of CTCF binding. These advantages have led to the increasing use of ChIP-Seq for genome wide 
transcription factor and histone modification mapping studies in vertebrates [53]. 
Mosquito genes important for development, immunity, blood feeding, and sex 
differentiation are of particular interest for the purpose of implementing novel strategies for the 
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control of pathogen transmission. The bithorax complex in Drosophila melanogaster has been 
well studied, revealing seven frontal abdominal insulator sequences. Among these sequences, six 
have been shown to be bound by or predicted to be bound by CTCF, with Fab 7 being the only 
exception [45]. Three more CTCF binding sites have also been identified in the region [45]. 
Frontal abdominal 8 (Fab 8) has been shown to have enhancer blocking activity [43] and has 
been implicated in the transcriptional regulation of genes within the bithorax complex. An 
understanding of CTCF’s role in the transcriptional regulation of the An. gambiae bithorax 
complex may lead to an improved understanding of the gene networks governing mosquito 
development. An understanding of the regulation of immunity genes may lead to the use of the 
mosquito’s own immune system to combat pathogen infection and thus reduce transmission.  
Genes which are important for blood feeding, such as some heme- peroxidase genes which 
produce anticoagulants and vasodilators, are important for increasing host susceptibility to 
pathogen infection and could similarly be manipulated for disease transmission control [25, 54]. 
Sex differentiation genes could be manipulated to improve efficiency of the sterile insect 
technique [15]. A genome-wide CTCF binding map would be useful for the study of these 
important systems in order to potentially take advantage of them for pathogen or vector control 
purposes. 
2.2 Materials and Methods 
2.2.1 Identification of potential CTCF binding sites in silico 
 Dr. Igor Sharakhov (Virginia Tech University) provided images from polytene 
chromosome spreads mapped with BAC clones and bound with a polyclonal antibody generated 
against the C-terminal region of An. gambiae CTCF [50], which were used to identify regions of 
CTCF binding. Dr. Sharakhov’s lab also provided nucleotide coordinates for the euchromatic 
and heterochromatic regions of each chromosome. Fluorescent in situ hybridization (FISH) was 
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used to hybridize and localize the PCR products of gene fragments believed to be located near 
euchromatin/heterochromatin boundaries, thus identifying the most accurate boundary 
coordinates possible [55]. This data was used to identify heterochromatin/euchromatin transition 
zones.  
DNA sequences identified from the above data and a position specific scoring matrix for 
the Drosophila CTCF consensus published by Holohan et al. (2007) [45] were input into Patser 
[56] to identify potential CTCF binding sites in the Anopheles gambiae genome. DNA sequences 
identified as similar to the consensus with Patser scores greater than 11 were manually analyzed 
for similarity with the Drosophila CTCF consensus published by Bartkuhn et al.(2009) [52]. The 
DNA sequences with the highest similarity were selected for validation using ChIP-PCR by 
designing primers flanking putative binding sites and allowing the amplification of 200 to 400 
base pair regions. Chromatin Immunoprecipitation was performed using the Upstate ChIP Assay 
Kit (Temecula, CA). The targeted amplicons were amplified using the following PCR 
amplification conditions; step 1: 3 minutes at 94oC, step 2: 15 seconds at 94oC, step 3: 30 
seconds at the determined annealing temperature, step 4: 1 minute at 72oC, step 5: steps 2-4 
repeated 39 times, step 6: 5 minutes at 72oC, step 7: held at 4oC. 
2.2.2 Anti-CTCF ChIP using Sua 4 cultured cells 
 Approximately 1x106 Sua 4 (neonate larval) cells were cultured in a 25cm2 cell culture 
flask with 10 ml of Schneider’s media with 20% fetal bovine serum containing antibiotics and 
fungizone. Proteins were crosslinked to genomic DNA by adding 1% formaldehyde to each flask 
of cells and incubating the cells at 37oC for 10 minutes. The cells were then washed twice with 
ice cold PBS containing protease inhibitors and scraped into a conical tube. The cells were then 
centrifuged and the supernatant was removed. The cells were resuspended in lysis buffer and 
incubated on ice for ten minutes. The chromatin was sheared by sonication into fragments of 100 
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to 400 base pairs. After sonication, 1% of the sample (20µl) was collected to be used as a control 
and checked for shearing efficiency. The control sample was incubated for 4 hours with 1µl of 
5M NaCl to reverse the crosslinks. DNA was purified and extracted using phenol/chloroform 
extraction and ethanol precipitation. The DNA was loaded onto a 1.5% gel and run at 96 volts 
for 30 minutes. Visualization of the DNA following ethidium bromide staining of the gel 
indicated that the DNA fragments were between 100 and 200 base pairs. 
 The remainder of the sonicated sample was pre-cleared with 75 µl of Protein A 
Agarose/Salmon sperm DNA for 30 minutes at 4oC with agitation. The Protein A 
Agarose/Salmon sperm DNA beads were pelleted by centrifugation and the supernatant was 
collected and immunoprecipitated with 6µl of An. gambiae CTCF antiserum (1:300 dilution) 
overnight at 4oC with rotation.  The immunoprecipitated sample was incubated with 60 µl of 
Protein A agarose/Salmon sperm DNA with rotation for 1 hour. The agarose beads were pelleted 
by centrifugation. The supernatant was removed and the protein A agarose/antibody/histone 
complex was washed for 5 minutes with each of the following reagents, in the following order: 
Low Salt Immune Complex Wash Buffer, High Salt Immune Complex Wash Buffer, LiCl Wash 
Buffer,  and TE Buffer (two washes)(Millipore, Temecula, CA). The DNA/protein complex was 
eluted by washing the agarose bead pellet twice in 250 µl of elution buffer (1% SDS, 0.1M 
NaCO3) for 15 minutes. The crosslinks of the combined eluates were then reversed by incubating 
the sample with 20 µl 5M NaCl for 4 hours at 65oC. Proteinase K digestion was performed to 
eliminate any remaining antibody and chromatin proteins. DNA was extracted and purified by 
phenol/chloroform extraction and ethanol precipitation.  
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2.2.3 ChIP-Seq library preparation 
 The immunoprecipitated DNA was used to prepare a ChIP-Seq library using the 
Illumina ChIP-Seq DNA Sample Prep kit (SanDiego, CA). Briefly, end repair of the DNA 
fragments was performed with T4 DNA ligase and dNTPs, followed by the addition of adenine 
bases to the repaired fragment ends. Adapters were then ligated to the DNA fragments. PCR 
amplification was performed with adapter specific primers and the library was run on a 2% gel at 
120V for 1 hour.  A 200 to 300 base pair sized fragment was excised from the gel and the DNA 
was gel extracted using the Qiagen gel extraction kit (Qiagen Sciences, Maryland).  
2.2.4 Real-time PCR for validation of the ChIP-Seq library 
 A real-time PCR experiment was performed using two samples each with the same mass 
of DNA template. One sample consisted of DNA from the ChIP-Seq library prepared from the 
CTCF immunoprecipitated DNA and the other consisted of input DNA prepared with adapters. 
Both samples were amplified with Sybr Green (Thermo Scientific) and primers flanking the 2R 
EuHet fragment, which was validated for CTCF binding using a gel based PCR assay. Each 
sample was assayed in triplicate on a real-time PCR plate using the Applied Biosystems 7300. 
The following PCR protocol was used: 3 minutes at 95oC; 40 cycles of 30 seconds at 95oC 
followed by 30 seconds at 60oC; 30 seconds for each of the following  temperatures: 70oC, 75oC, 
80oC, 85oC, 90oC, 95oC; held at 4oC [57]. 
2.2.5 Sequencing and analysis of the CTCF immunoprecipitated ChIP-Seq library 
Sequencing of the prepared library was performed at the IGSP Genome Sequencing and 
Analysis Core Resource at Duke University in Durham, NC using Illumina GAIIx sequencing 
technology. The sequence data was modified using various tools in the Galaxy suite [11, 58, 59]. 
FASTQ Groomer[60] was used to format the data and the data was aligned to the ensembl 
AgamPEST3 [3, 61] version of the Anopheles gambiae genome using Bowtie[62].  
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The control library was prepared from input DNA from the same Sua 4 cell line using 
the same extraction and purification protocol as described above, without the 
immunoprecipitation step. The input DNA was sent to the IGSP Genome Sequencing and 
Analysis Core Resource at Duke University in Durham, NC for Illumina ChIP-Seq library 
preparation and Illumina GAIIx sequencing. After alignment to the AgamPEST3 [3, 61] version 
of the genome using Bowtie [62], Model-based Analysis for ChIP-Seq (MACS)[63] was used to 
identify peaks of sequence enrichment from the CTCF antibody immunoprecipitated library 
throughout the genome, using the input library as a background control, as described in [63]. 
Throughout this work these peaks will be referred to as CTCF binding site peaks. It is important 
to note that these CTCF binding site peaks may contain one or multiple CTCF binding sites 
within the given coordinates identified by MACS [63]. For parameters used to run MACS, see 
supplementary material. Annotation of the MACS data was performed with annotationPeaks 
from the Homer suite [44] in conjunction with the ensemble AgamPEST3 [3, 61] version of the 
An. gambiae genome.  
2.3 Results 
2.3.1 In silico identification and validation of a CTCF binding site 
Dr. Igor Sharakhov’s lab (Virginia Tech University) provided images of polytene 
chromosome spreads obtained from An. gambiae ovarian nurse cells bound with a polyclonal 
antibody generated against the C-terminal region of An. gambiae CTCF [50]. Figure 4 is an 
image of part of the 2R chromosomal arm treated with this antibody. This procedure identified 
CTCF binding regions along at least two of the chromosome arms. Chromosome arms 2L and 
2R were hybridized with BAC clones as reference points to identify the chromosomal positions 
of the CTCF binding regions distributed along the chromosome arms. Regions of fluorescence 
along the chromosomes indicated regions of CTCF antibody accumulation, identifying regions 
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of CTCF binding with a resolution of approximately one megabase. Coordinates for the 
euchromatic and heterochromatic regions of An. gambiae ovarian nurse cell chromosomes, 
provided by the Sharakhov lab were used to identify euchromatin/heterochromatin transition 
zones. The chromosome spreads treated with the CTCF antibody indicate that 
euchromatin/heterochromatin transition zones may be regions of enriched CTCF binding.  
 
 
 
Figure 4: Chromosome 2R from an An. gambiae ovarian nurse cell stained with the An. 
gambiae CTCF antibody. CTCF binding regions are indicated by white bands. Asterisks 
indicate regions that are syntenic with CTCF binding regions in An. stephensi. The arrow head 
indicates a CTCF binding region unique to An. gambiae. 
  
 
To identify potential CTCF binding sites, we used a position specific scoring matrix 
(PSSM) for the Drosophila consensus, as published by Holohan et al. [45] based on their 
Drosophila CTCF microarray data. The PSSM was input into the bioinformatics perl program, 
Patser [56], with sequences corresponding to regions of the chromosomes identified as CTCF 
binding regions via the CTCF antibody-stained chromosome spreads, or 
euchromatin/heterochromatin border regions identified by the Sharakhov lab[44] . The Patser 
output showed multiple DNA sequences with similarity to the Drosophila consensus, with scores 
corresponding to their level of similarity.  
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To identify the output sequences that were most likely to be actual sites of CTCF 
binding, a lower threshold Patser score was established by entering sequences from the 
Drosophila genome that contained CTCF binding sites that were experimentally identified by 
microarray analysis [45] into Patser with the Drosophila CTCF consensus PSSM [45], and 
identifying the sequences in the Patser output that corresponded to the experimentally identified 
sequences. These sequences had a Patser score of 11 or higher. Sequences with scores lower than 
11 did not correspond to experimentally identified CTCF binding sites. Therefore, a score of 11 
was used as a minimum threshold for output sequences to be considered DNA sequences with 
likely similarity to the Drosophila CTCF binding consensus. Each one of the output sequences 
with a score of at least 11 was compared to the Drosophila CTCF binding consensus published 
by Bartkuhn et al. (2009) [52]. This consensus was used based on its increased accuracy due to it 
being generated from a data set of 300 experimentally identified CTCF binding sites, compared 
to only 33 for the Holohan consensus. Those output sequences with the highest similarity to the 
consensus were considered potential CTCF binding sites and were tested for confirmation by 
ChIP-PCR. 
One potential binding site was identified on chromosome 2R within a euchromatic 
region, near a euchromatin/heterochromatin border at base pair position 59,016,524. This 
potential binding site was validated with ChIP-PCR using primers that flanked the potential 
binding site, producing a 200 base pair amplicon (Figure 5). Input DNA was amplified to be 
used as a positive control, DNA immunoprecipitated with normal rabbit serum was used as a 
negative control reaction and a no template control was also utilized. The resulting gel, shown in 
figure 5, clearly showed PCR products from the input and CTCF immunoprecipitation reactions. 
No PCR products were generated from the normal rabbit serum immunoprecipitation and the no 
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template control reactions. This validated potential binding site was used as a positive control for 
ChIP-Seq library preparation (see Materials and Methods). 
 
 
 
Figure 5: ChIP-PCR result for potential CTCF binding region found on chromosome 2R at 
position 59,016,524 bp. Input is amplification using non-immunoprecipitated DNA as template. 
CTCF IP: Immunoprecipitated with CTCF antiserum. NRS IP: Immunoprecipitated with normal 
rabbit serum. NTC: no template control 
 
 
 
 
2.3.2 CTCF binding site peaks identified via ChIP-Seq are over-represented near genes 
 The annotationPeaks tool from Homer [44] used the MACS [63] data and the ensembl 
AgamPEST3 [3, 61] reference genome to identify whether CTCF binding site peaks   were found 
within an intron, promoter, exon, transcription termination site (TTS), 5’UTR, 3’UTR, or 
intergenic region. Of the entire data set, 51% are within intergenic regions, and 28% of the 
intergenic peaks are within 10kb upstream of a promoter, and 14% of them are within 10kb 
downstream of a promoter. The large amount of intergenic sequence in the genome could 
explain this result by random distribution. However, given that 42% of CTCF binding site peaks 
are located in close proximity to genes and gene clusters, as well as the gene insulating property 
of CTCF identified in other organisms, it is likely that CTCF is acting as an insulator at many of 
these intergenic positions. Further experimental analysis is necessary to determine the function 
of the CTCF binding site peaks at intergenic positions.  
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 Another interesting result is the presence of 16.7% of the identified CTCF binding site 
peaks within the promoter region of a gene, defined by the Homer software, annotationPeaks, as 
the range of 1000 base pairs upstream of the transcription start site to 1000 base pairs 
downstream of the transcription start site [64]. This is consistent with earlier evidence of the 
transcriptional activating and repressing roles of CTCF. The identification of the functional roles 
of these identified CTCF binding site peaks will require further study. 
 The Homer annotation also revealed that 17.7% of the CTCF binding site peaks in the 
data set were found within introns, 6.25% of the peaks were found within exons, and 7.3% were 
found at transcription termination sites (TTSs). Shukla et al. [65] provide an explanation as to 
how intragenic regulation by CTCF may occur, the details of which are presented in the 
discussion section. RNAi depletion of CTCF confirmed that CTCF binding to an exon was 
responsible for alternative splicing of the human gene, CD45, resulting in the inclusion of the 
exon [65]. Other models have been put forth, suggesting that insulators bound by CTCF within 
the introns of genes are responsible for repression of these genes. It has been shown that 
methylation of a CTCF binding site within an intron inhibits CTCF binding and leads to 
increased transcription of the gene. This is the case for the human oncogene BCL6, which is 
upregulated due to aberrant methylation in the first intron, leading to a lack of CTCF binding at 
this locus in lymphoma cells [66]. This supports the notion that a CTCF binding site at an intron 
may act as a repressor. 
 The results of this ChIP-Seq study show that the majority of CTCF binding sites in the 
An. gambiae genome are situated near or within genes. Based on the amount of intergenic 
sequence within the genome, a random distribution of CTCF binding sites should result in close 
to 90% of the peaks being intergenic. This value was estimated using data from the AgamPest3 
genome on vectorbase.org [3, 67, 68]. The average length of an An. gambiae gene was estimated 
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by comparing the longest and shortest genes in the genome. This average length was estimated 
on the high end in order to err on the side of less intergenic sequence. The average gene length 
was multiplied by the number of genes in the AgamPest3 genome. This number of base pairs 
represents the amount of the genome that is gene sequence (10% of the genome). This was 
subtracted from the total number of base pairs in the genome to estimate the amount of 
intergenic sequence in the genome. The number of intergenic peaks is well below this random 
expectation, at 51%. Also, 17.7% of the CTCF binding site peaks are found within introns and 
16.7% are found within promoters. Thus, nearly half of the potential CTCF binding sites are 
within genes, similar to the binding pattern of other transcription factors, such as CREB1 [69]. 
Figure 6 illustrates the frequency of CTCF at the six genic contexts defined by the Homer 
annotaionPeaks software [64]. This suggests that CTCF may be necessary for maintaining 
appropriate transcript levels of many genes throughout the An. gambiae genome, as has been 
shown in other organisms [42]. It is important to note that percentages of CTCF binding sites 
mapped to their relative genic positions in the An. gambiae genome are similar to those in the 
human genome, which has 46% mapped to intergenic regions, 20% mapped to promoters, 12% 
mapped to exons, and 22% mapped to introns [42]. According to microarray data, D. 
melanogaster has a similar distribution of CTCF binding sites [52]. Thus, CTCF appears to be 
conserved at least in regard to its binding site positions relative to genes throughout the genome 
from humans to dipterans. Further studies will be needed to determine whether this conservation 
extends to the multiple functional roles of CTCF throughout the genome.  
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Figure 6: Distribution of CTCF ChIP-Seq peaks in the An. gambiae genome. 5’UTR and 3’ 
UTR represent peaks located within the 5’ and 3’ untranslated regions of annotated genes, exons 
represent peaks located within coding regions of annotated genes, excluding promoter 
sequences. Intergenenic regions represent peaks located outside annotated genes, also excluding 
promoter sequences. Introns represent peaks located within non-coding DNA between exons. 
Promoters represent peaks found within 1000 bp upstream of an annotated transcription start site 
and 100 bp downstream of a transcription start site. TTSs represent peaks located at a 
transcription termination site 
 
2.3.3 CTCF binding site chromosome map 
The CTCF binding site ChIP-Seq data was mapped to individual chromosome arms 
according to the chromosome band coordinates for the AgamP3 genome available on 
vectorbase.org [3, 67, 68]. Some of the chromosome bands are not represented on 
vectorbase.org. According to vectorbase.org personnel (personal communication), all of the 
assembled sequence is present; however, sequences that would be designated as part of the 
Distribution of CTCF ChIP-Seq 
peaks in the Anopheles gambiae 
genome 3’ UTR (0.5%) 
5’ UTR (1%) 
exons (6.25%) 
intergenic regions 
(51%)  
introns (17.7%) 
promoters (16.7%) 
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missing chromosome band have been designated as part of a neighboring band. Therefore, some 
of the peaks assigned to specific chromosome bands in this work may actually be present in 
other chromosome bands not identified on vectorbase.org. Figure 7 shows all five chromosome 
arms with their respective bands as identified on vectorbase.org with lines of varying lengths 
indicating the relative number of CTCF binding site peaks identified within the corresponding 
chromosome band.  
The CTCF immunostained chromosome spreads were compared to the chromosome 
map. This comparison showed some correlation between regions of CTCF binding identified on 
the chromosome spreads with the ChIP-Seq data identified along the chromosomes. Figure 8 
shows the chromosome spreads with lines of varying length along them indicating the number of 
CTCF binding site peaks for the vectorbase.org chromosome band corresponding to those 
particular chromosomal regions. The intensity of the immunostaining signal does not always 
correlate with the number of ChIP-Seq peaks at a particular chromosome band.  This may be 
caused by differences in CTCF affinity among the different sites, resulting in lower signal 
intensity on the chromosome spreads. The different cell types used in these experiments may 
also explain these differences [70]. The chromosome spreading procedure can also affect the 
resolution of the immunostaining signals along the chromosomes. However, some chromosome 
bands showed signals of CTCF binding on the chromosome spreads correlating with the number 
of CTCF binding site peaks. These included 8A, 8B, 8E (at BAC clone 12_G10), 9A, 9C, 11A, 
11C, 12B, 12C, and 12E on chromosome 2R, and 20A (designated as the centromere on 
vectorbase.org), 20C, 21B (at BAC clone 02A19), and 21D on chromosome 2L.  
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Figure 7: Distribution of CTCF binding site peaks along the five An. gambiae chromosome 
arms. Varying lengths of lines for the chromosome bands as identified on vectorbase.org 
indicate the relative abundance of identified CTCF binding site peaks for  
each chromosome band. 
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A) 
 
 
 
 
 
 
 
B) 
 
Figure 8: Distribution of CTCF binding site peaks at chromosome bands compared to 
chromosomes immunostained with the CTCF antibody. A) Chromosome 2L chromosome 
spread. B) Chromosome 2R chromosome spread. White immunostained bands indicate regions 
of CTCF binding. White vertical lines of varying lengths indicate the relative abundance of 
CTCF binding site peaks at each chromosome band at that location. 
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Table 2: ChIP-Seq identified CTCF binding sites validated by ChIP-PCR. The left column 
identifies the genomic location of the CTCF binding site peaks relative to nearby genes of 
significance. Top: The template used for the individual PCR reactions. Input refers to non-
immunoprecipitated DNA. CTCF IP refers to DNA immunoprecipitated using the antibody 
raised against An. gambiae CTCF. NRS IP refers to DNA that was Immunoprecipitated using 
normal rabbit serum. NTC refers to no template control 
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2.3.4 Some immune response genes may be regulated by CTCF 
CTCF binding sites proximal to some immune response genes were selected for 
validation (see Table 2) because of the possibility that CTCF may play a role in the regulation of 
these genes. An improved understanding of the regulation of immune response genes will aid in 
the development of a malaria transmission control program. The CLIP genes are a family of 
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immune response genes that regulate melanization. One cluster of eight CLIP genes is between 
two CTCF binding site peaks 60 kb apart. CLIPB3 and CLIPB4 have been shown to be 
necessary for ookinete melanization. Two other important CLIP genes, CLIP A2 and CLIP A5, 
are found within a gene cluster with ten other CLIP genes between two CTCF binding site peaks, 
89.5 kb apart. CLIPA2 and CLIPA5 are known to block ookinete melanization. In both cases, 
the flanking positions of the CTCF binding site peaks, relative to the CLIP gene clusters, suggest 
an insulating role for CTCF at these genomic locations based upon results in other organisms 
that indicate that genes and clusters of genes are insulated by flanking insulator sequences, such 
as the genes of the bithorax complex in D. melanogaster [71]. 
 CTCF binding site peaks are also located at the promoter of two CLIP genes. The CTCF 
binding site peak associated with the CLIPB17 promoter is isolated with no other CTCF binding 
site peaks within 500 kb in the upstream direction and nearly 400 kb in the downstream 
direction. In contrast, the CTCF binding site peak at the CLIPA8 promoter is accompanied by 
another CTCF binding site peak located just 4.4 kb upstream of the promoter.  
 Another gene important for immunity is cact (cactus), which has a CTCF binding site 
peak at its promoter. Just downstream of cact, another CTCF binding site peak is present within 
exon 2 of the novel gene, AGAP007941. Although the function of this gene is unknown, it 
presents an opportunity to study the possible role of CTCF as an intragenic regulator. 
2.3.5 CTCF binds near some heme-peroxidase genes 
Heme-peroxidase genes have been shown to be associated with immunity and blood 
feeding in mosquito species. Therefore, further understanding of the transcriptional regulation of 
these genes may be useful for malaria transmission control. With this in mind, a subset of CTCF 
binding sites near some Heme-peroxidase genes were validated by ChIP-PCR, as shown in Table 
2. An Immunomodulatory peroxidase (IMPer), identified as HPX15 in the An. gambiae genome, 
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has been shown to combine with dual oxide to protect the midgut lumen from immune responses 
which allows for the survival of commensal bacteria, consequently allowing Plasmodium 
ookinetes to survive in the midgut [72]. HPX 15 is located within a 337.8 kb segment of the 
genome between two CTCF binding site peaks with HPX 14 and 10 novel genes. Peroxidase 
activity has also been observed in female Anopheles albimanus mosquitoes before blood feeding 
and has been shown to be associated with the inactivation of vasoconsticting substances 
necessary to form hemostats. [25]. Some Heme-peroxidase genes in the An. gambiae genome 
have CTCF binding site peaks in close proximity. Further study of the function of CTCF, as well 
as the identification of other proteins in complexes at these CTCF binding regions may provide 
more insight regarding the regulation of genes such as HPX15 and others that may be important 
for blood feeding. 
Heme-peroxidase 6 (HPX 6) is positioned within a 53.67 kb region between two CTCF 
binding site peaks that also contains 6 novel genes. The positioning of the peaks suggests that 
they may insulate the genes within the intervening sequence. According to CTCF looping 
models previously described in Chapter I [42], the sequence between the two CTCF binding site 
peaks may form a loop that is isolated from inappropriate enhancer or silencer interactions. This 
would maintain HPX 6 and the other genes within the 53.67 kb region at their appropriate 
expression levels. HPX 16 and HPX 2 are also located within similar regions between flanking 
CTCF binding site peaks. HPX 10 and HPX 11 are located within another region between CTCF 
binding site peaks, which they share with several cuticular proteins. In these cases the genomic 
region is no larger than 136 kb and no smaller than 10 kb. The looping model says that in order 
for a loop to be formed, a genomic region needs to be at least 10 kb in length [42]. However, 
looping is not the only possible mechanism for insulating genes from enhancers. Single insulator 
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sequences have also been shown to effectively block the activity of genomic elements that may 
alter gene transcription [38]. 
Another heme-peroxidase gene, HPX 4, has a CTCF binding site positioned within the 
intron of an alternative splice variant and 22.2kb upstream of the other splice variant. A second 
CTCF binding site peak is 1.7kb downstream of both splice variants. The CTCF binding site 
positioned at the first intron of the longer variant may be responsible for distinguishing between 
the two variants, as is the case mentioned previously in which CTCF has been shown to be 
necessary for distinguishing between splice variants depending on whether or not the binding 
site is bound by CTCF [65]. The short variant does not begin to be transcribed until the sixth 
exon and has one extra intron. Further study will be necessary to determine if and how CTCF 
distinguishes between these two splice variants. This presents an opportunity for the study of the 
possible intragenic regulatory function of An. gambiae CTCF. 
2.3.6 CTCF and sex differentiation genes 
CTCF binding sites were validated and or analyzed near sex differentiation genes due to 
the possibility that they may play a role in the transcriptional regulation of such genes. 
Understanding the transcription of sex differentiation genes would be useful for improving the 
efficiency of the sterile insect technique. Doublesex is responsible for the normal expression of 
secondary sexual characteristics in Drosophila [73]. The CTCF binding site peak data was 
compared with a consensus  sequence for the Aedes aegypti doublesex binding site, provided by 
Dr. Helen Benes (University of Arkansas, Little Rock), using Patser [56]. Doublesex has well 
conserved DNA binding sites across dipteran species [73]. Patser identified 97 sequences among 
the 2,416 CTCF binding site peak sequences (~4% of total peaks), that are similar to the position 
specific scoring matrix (PSSM) of the Aedes aegypti doublesex binding motif.  
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Male sex lethal 2 (MSL-2) is the protein necessary for dosage compensation in male 
Drosophila. Dosage compensation is accomplished in male Drosophila by doubling the amount 
of mRNA produced from the X chromosome. In females, ectopic MSL-2 expression results in 
the doubling of mRNA on both X chromosomes and thus results in lethality. MSL-2 expression 
in females is regulated by the Sex-lethal protein, which binds to the 5’ and 3’ UTR of msl-2 
mRNA to inhibit its translation. 
The An. gambiae msl-2 ortholog is found within a 34.8 kb region flanked by two CTCF 
binding site peaks, suggesting a possible insulator function for these two binding sites. The An. 
gambiae ortholog for sex-lethal has a CTCF binding site peak at the promoter of its shorter 
splice variant, which is within the first intron of the longer splice variant. The gene is also 
positioned near the middle of a 58.9 kb sequence flanked by two CTCF binding site peaks. The 
positioning of these peaks suggests an insulator function for the two flanking peaks. The peak 
found at the promoter/intron of the two splice variants suggests a possible activator/repressor 
function or intragenic regulation role, perhaps in directing alternative splicing events. This is 
another candidate region for the further study of An. gambiae CTCF function.  
2.3.7 CTCF binding site peaks at the Anopheles gambiae bithorax complex 
The bithorax complex in insects is important for determining the insect body plan during 
development. Expression levels of specific genes must be maintained at specific embryonic 
locations and developmental time points to guarantee correct development of each body 
segment. At the Drosophila bithorax complex, CTCF has been shown to play an important role 
in insulating specific bithorax complex transcriptional regulatory regions from one another. 
CTCF binding sites have been identified at nine different locations within the Drosophila 
bithorax complex [45]. Two are between ultrabithorax (ubx) and abdominal A (abd-A), the 
binding site in the 5’ direction coincides with the predicted insulator known as frontal abdominal 
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2 (Fab-2). The binding site that is downstream of Fab-2 has the designation of A.  Five more are 
between abd-A and abdominal B (abd-B) and correspond to the predicted insulators Fab-3 and 
Fab-4, as well as to the genetically identified insulators Mcp (Miscadastral pigmentation), Fab-
6, and Fab-8 insulators [45]. Two more binding sites are upstream of abd-B and have been 
designated as B and C. Fab-8 has been shown to be an important boundary between the Abd-B 
transcriptional regulatory regions of iab-7 and iab-8. The iab-7 and iab-8 regulatory sequences 
initiate and maintain the specific expression patterns of Abd-B for parasegments 12 and 13 
respectively. Removal of the Fab-8 sequence results in the fusion of these transcriptional 
regulatory regions, resulting in the loss of the parasegment 12 expression pattern, which is 
replaced by Parasegment 11 and parasegment 13 expression patterns in the Drosophila embryo 
[74]. Not only does CTCF bind to the Fab-8 sequence, it has been shown to be necessary for 
maintenance of the enhancer blocking activity of the Fab-8 barrier between the iab-7 and iab-8 
transcriptional regulatory regions [43, 46]. 
With this in mind, we looked at the CTCF binding site peaks in the An. gambiae 
bithorax complex. Figure 9E illustrates the An. gambiae bithorax complex with black peaks 
representing CTCF binding site peaks, compared with CTCF binding sites previously identified 
in Drosophila, represented with blue peaks. The An. gambiae ChIP-Seq data reveal two CTCF 
binding site peaks flanking a 584 kb region containing the bithorax complex, composed of the 
orthologs of ubx, abd-A, and abd-B. Three more CTCF binding site peaks were identified 
between abd-A and abd-B. Based on their location with respect to the orthologous genes, these 
peaks appear to correspond to the Fab-3, Fab-4, and Fab-8 insulators in D. melanogaster [45, 
52]. The peak upstream of abd-B was validated by ChIP-PCR, as shown in Table 2. The peak 
downstream of ubx was unable to be validated due to the repetitive sequences within the peak 
region. However, primers were able to be designed for a 211 base pair region, 47 base pairs 
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downstream of the called peak region. This region was shown to bind CTCF using ChIP-PCR, as 
shown in Table 2. The three peaks identified between the two flanking peaks were unable to be 
validated by ChIP-PCR due to highly repetitive sequences in the region.  These data suggest that 
the An. gambiae bithorax complex has a similar organization to that of D. melanogaster. 
Unfortunately, the repetitive sequence in the vicinity of these three peaks prevented effective 
primer design for complete ChIP-PCR validation. 
 
 
A 
 
 
Figure 9: Maps of genomic regions with CTCF binding site peaks in relation to selected 
genes of interest. Pointed peaks represent CTCF binding site peaks identified by ChIP-Seq 
(width of peak is not to scale). The black line represents the DNA fragment under examination. 
The blue rectangles represent genes along the indicated DNA strand. The length and annotation 
of each gene are noted above or below the respective rectangles. Other genomic distances refer 
to distances between genes. Genes on top of the black line are on the forward strand and genes 
on the bottom of the black line are on the reverse strand. Promoters are indicated by arrows 
pointing in the direction of transcription. The red line at the bottom indicates the approximate 
base pair length for the indicated length. Figure 9D shows more detail of the individual 
transcripts with blue rectangles indicating exons and blue lines indicating introns. The white box 
at the 5’ end of the long transcript indicates the 5’ untranslated region. Figure 9E labels An. 
gambiae CTCF binding site peaks and Drosophila CTCF binding sites with the homologous D. 
melanogaster insulator identifier. Light blue peaks indicate Drosophila CTCF binding sites. 
Base pair distances refer to distances between genes and CTCF binding site peaks identified in 
An. gambiae. Insulators in quotes refer to predicted insulators. Italicized insulators refer to 
insulators that have been genetically identified. 
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2.3.8 Four sequence motifs identified among a subset of the CTCF binding site peaks 
The following criteria were used to select a subset of CTCF binding site peak sequences 
for analysis to identify a CTCF binding site consensus: (1) the CTCF binding site peak 
sequences corresponded to a chromosome band that showed enrichment for CTCF on the CTCF 
immunostained chromosome spreads, and/or (2) were validated for CTCF binding by ChIP-PCR.  
There was only one biological replicate of CTCF ChIP-Seq data; therefore, the CTCF 
immunostained chromosome spread data and the ChIP-PCR validated sequences provided  an 
additional biological replicate of a set of sequences representing CTCF binding sites with high 
confidence. Two-hundred-twelve peaks met these criteria, these were analyzed using the motif 
finding tool, AlignACE [75] from the Tmod software suite (Toolbox of motif discovery) [76], 
which uses a Gibbs sampling algorithm to identify motifs from multiple sequences through 
alignment of similar sequences. Fifty-four motifs were identified from the data set. Four of these 
motifs, motif 17, motif 24, motif 27, and motif 29 were relatively conserved across at least 3 
base pair positions with relatively low repetitiveness and represented 24%, 19.3%, 25%, and 
19.8% of the 212 sequences input into AlignACE, respectively. After identifying and subtracting 
duplicate sequences among the four motifs, it was shown that these four motifs are represented 
in approximately 54% of the sequences input into AlignACE.  
Figure 10 shows the Logos representation of the four discovered motifs, which illustrate 
the conservation of the individual nucleotides at the specified positions by the height of the 
letters representing each nucleotide. Motif 27 is represented in 25% of the sequences input into 
AlignAce and is 82% unique from the motif that accounts for the next highest percentage of 
input sequences, motif 17.  These two motifs, together, are represented in 45% of the input 
sequences after subtracting duplicate sequences. The other two motifs, 24 and 29 combined, are 
represented in 33% of the input sequences. Twenty-three of the input sequences are unique to 
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motif 17, 16 are unique to motif 27, 11 are unique to motif 24, and 13 are unique to motif 29. 
Therefore, 63 of the 115 CTCF binding site peak sequences with one of these motifs (55%) 
contain a single motif. The remaining 45% of the CTCF binding site peak sequences contain 
multiple motifs. The CTCF binding site peak labeled as 2R_171, which is found at the promoter 
sequence of AGAP002418, which codes for a cytochrome P450 protein, contains all four motifs 
within its 216 bp sequence. Other CTCF binding site peak sequences contain more than one of 
the identified motifs; eighteen contain three of the motifs and 27 contain two of them. 
The Perl Program, Patser [56], was used to search for the four motifs among the 2,416 
identified CTCF binding site peaks. To do this, alignment matrices were constructed using the 
aligned sequences from the AlignACE output which were input into the enoLogos online 
software [77]. A position specific scoring matrix for each of the four motifs was constructed and 
input into Patser with the 2,416 CTCF binding site peak sequences. Motifs 17, 24, 27, and 29 
were identified among only 11.9%, 7.8%, 8.3%, and 8.4% of the entire ChIP-Seq dataset, 
respectively. 
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Figure 10: Logos representing the motifs identified from among the 212 CTCF binding site 
peaks. These motifs had relatively low repetitiveness and longer sequences of continuously 
conserved bases compared to the remaining motifs identified by AlignACE. 
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2.4 Discussion 
2.4.1 The distribution of CTCF binding sites likely reflects its multiple putative functions                
This ChIP-Seq experiment has identified 2,416 regions of CTCF binding throughout the 
An. gambiae genome ranging in size from 48 bp to 1,970 base pairs, with 62% of the data set 
between 100 and 200 base pairs. The identification of regions of CTCF binding, defined in this 
work as CTCF binding site peaks, throughout the An. gambiae genome will aid in the 
identification of insulator sequences that could be used to insulate a transgene that is inserted 
randomly into the genome. It will also aid in further research of the transcriptional regulation of 
genes that are important for developing an effective genetic strategy for controlling mosquito 
borne disease transmission.  
CTCF has been shown to be an important factor across multiple species from humans to 
Drosophila [43]. Orthologs have been identified in human, chicken, mouse, Xenopus, zebra fish, 
cattle, tammar wallaby, platypus, central bearded dragon, D. melanogaster, Ae. aegypti, and An. 
gambiae [42, 78]. CTCF is highly conserved across these species within its eleven zinc finger 
domains, which is believed to provide its multifunctional properties. CTCF has been suggested 
to be a master weaver of multicellular genomes, with possible functions in nucleosome 
positioning, enhancer blocking, maintaining heterochromatin boundaries, mediating cis and trans 
long range chromatin interactions, imprinting, and X chromosome inactivation [41]. A 
model put forth to explain CTCF’s multiple functions is the CTCF code, which identifies its 
ability to bind to multiple sequences by using different combinations of Zinc fingers as the 
mechanism responsible for its multiple functions [42]. Therefore, according to this model, the 
sequence of the binding site determines the function of CTCF by exposing different protein 
binding domains. Ohlsson et al.  (2010) [42] also note that chromatin context influences CTCF 
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protein interaction and function. It has been shown that CTCF binding sites display insulator 
function in a plasmid-based insulator assay; however, these sites might have alternative 
properties in other assays, due to different chromatin contexts[42]. Transcription factor binding 
sites such as the thyroid hormone response elements can modulate CTCF function [42, 59]. 
Methylation is also known to antagonize CTCF binding. The correlative data of CTCF’s 
presence at H3K27me3/H2AK5ac borders implies a need for cooperation between CTCF and 
chromatin modifiers [42, 62, 63]. Thus, in addition to the underlying sequence of the binding 
site, multiple factors in the chromatin context also appear to contribute to determining the 
function of CTCF [42].  
CTCF has multiple protein binding partners including other CTCF molecules, which are 
determined by the available protein binding domains. The binding sequence and the chromatin 
context appear to determine the availability of a particular protein binding domain at a particular 
genomic position. This ability to expose different protein binding domains, determined by the 
DNA sequence it binds and the chromatin context of the binding site, also leads to different post 
translational conformations such as poly(ADP-ribosyl)ation, SUMOylation,  and 
phosphorylation. These modifications are associated with different CTCF functions such as 
insulator function, transcriptional repression, and growth inhibition [42].  
The primary function of CTCF may be to spatially organize the genome with multiple 
DNA sequences and chromatin contexts throughout the genome, appropriately guiding the 
necessary interactions to do so. Enhancer blocking, chromatin boundary function, transcriptional 
activation and repression, as well as other functions mentioned above may simply be appendages 
of this primary function. It appears that the genome has a code to dictate the appropriate function 
of CTCF at the appropriate genomic location via specific sequence and chromatin context [42]. 
This makes the function of CTCF at individual binding sites difficult to predict, especially in 
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insect species that have multiple insulator proteins that interact with CTCF at a subset of the 
binding sites, which also appear to affect its function [44, 58]. 
The distribution of CTCF binding site peaks in relation to genes and within genes may 
be an indication of the role CTCF plays at each of its varying locations. As mentioned 
previously, CTCF is known to function as a repressor, an activator, an insulator, and more 
recently has been identified as playing a role in determining splice variants [65]. A majority of 
the identified CTCF binding site peaks are located in intergenic regions of the genome. We 
expected this to be the case, considering that one of CTCF’s functions is to act as an insulator 
between genes and gene transcriptional regulatory regions. However, considering the large 
amount of intergenic sequence in the An. gambiae genome (90%), it is interesting to note that 
only 51% of the identified CTCF binding site peaks are found to be intergenic. This suggests that 
at nearly half of the CTCF binding site peaks, CTCF is likely to be acting within genes, perhaps 
performing an intragenic regulatory function rather than or as well as insulating nearby genes 
from the genomic environment. 
2.4.2 What effects does CTCF have on neighboring genes? 
This data also showed that many of the intergenic CTCF binding site peaks were located 
proximal to genes, with 28% of them within 10 kilobases upstream of a promoter, and 14% 
within 10kb downstream of a promoter. The proximity to genes may indicate selective forces 
maintaining CTCF binding sites at these locations. It is likely that CTCF is important for 
regulating transcription of those genes near CTCF binding site peaks, as well as those genes 
containing CTCF binding site regions within their coding region. It is important to keep in mind 
that CTCF also has been shown to be involved in long distance interactions, which cannot be 
inferred from this data set. Ohlsson et al. (2010) [42] explain that CTCF function is likely 
determined by sequence and chromatin environment, and it has not been implied that genomic 
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position in relation to genes can definitively predict the effect of CTCF on neighboring genes 
[42]. Such questions regarding the effect of CTCF on nearby genes will have to be answered by 
testing hypotheses at each individual locus through genetic engineering techniques. Keeping in 
mind that the CTCF binding site peaks identified in this study may contain one or multiple 
binding sites, the relationship between CTCF and neighboring genes can be fairly complicated.  
However, previously identified CTCF binding sites identified near genes in other organisms can 
provide some insights.     
For CTCF binding sites located at the promoter region of genes, CTCF may likely be 
functioning as an activator or a repressor, such as has been identified in vertebrates at the APBβ 
promoter and c-Myc promoter respectively [79, 80]. For binding sites within intergenic regions, 
it is likely that CTCF may act as an insulator for nearby genes, isolating inappropriate enhancers 
from gene promoters. This is the case at the bithorax complex, whereby boundary elements 
maintain appropriate expression levels of ultrabithorax, abd A, and abd B in the appropriate 
parasegments, based on the location of insulator regions between the parasegment specific 
enhancers [73]. Other examples of intergenic CTCF binding sites have also been identified as 
insulators in vertebrates, such as the Igf2/H19 [37] locus and the chicken HS4 β-globin locus 
[81]. It should be noted that although CTCF has been shown to only function as an enhancer 
blocker at the cHS4 insulator and is independent of silencer blocking, the insulator sequence is 
responsible for silencer blocking [82]. Therefore, CTCF binding may be a useful genomic 
landmark for identifying insulator sequences even if a portion of the insulator function is 
independent of CTCF. To determine the function of CTCF at its DNA binding sites throughout 
the An. gambiae genome, it will be necessary to perform assays for individual binding sites 
similar to those used to identify the function of CTCF in the above mentioned organisms.  
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An EMSA assay, to determine the sequence bound by CTCF followed by a methylation 
interference assay, to determine the specific nucleotides required for CTCF binding, are two of 
the assays necessary to determine the affinity of CTCF at a given binding site. Once the binding 
sequence is determined through a competitive mobility shift assay, a mutated sequence could be 
synthesized to compare functionality with the wild type sequence in the appropriate transgenic 
assays necessary to determine the hypothesized function.  
To test repression or activation, as was done for the APBβ promoter and c-myc promoter 
[79, 80] a reporter gene assay could be performed by independently inserting the wild type and 
mutated sequences adjacent to the promoter of a reporter gene such as CAT (chloramphenicol 
resistant gene) or EGFP (enhanced green fluorescent protein), followed by transfection of the 
recombinant plasmid construct into cultured cells and integration into a chromosome. A similar 
assay could be performed to determine insulator function by inserting the sequences between the 
promoter of a reporter gene and a functional enhancer as performed by Li et al. (2008) [83]. 
These experiments can provide an indication of the role of CTCF at a genomic location based 
solely upon the binding site sequence; however, the sequences are not incorporated into their 
natural chromatin environment, and thus the CTCF functional role cannot be exactly determined 
at each natural binding site. 
 Site directed homologous recombination would be useful in determining the function of 
a CTCF binding site in vivo; however, for dipterans this is a difficult procedure and is not 
routinely performed even in D. melanogaster. The biological system necessary for efficient 
homologous recombination in mouse is not present in dipterans making such an endeavor 
extremely challenging, not to mention the repetitive nature of mosquito genomes at many of the 
CTCF binding sites adding to the difficulty of the task. The best option for determining the 
effects of chromatin environment on CTCF function would be to independently insert a wild 
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type CTCF binding site sequence and a mutated CTCF binding site sequence into the same 
location of the genome via a site specific integration system, such as ΦC31, to determine how 
CTCF functions in a particular chromatin environment. Multiple ΦC31 docking sites throughout 
the mosquito genome would allow for a variety of chromatin contexts within which different 
CTCF binding site sequences could be assayed for CTCF function. This experiment is based on 
results that showed that insulator sequences integrated into the genome can determine the 
nuclear localization of DNA, as determined by Gerasimova et al.(2000) [84] in the case of the 
gypsy insulator [84]. 
Binding site regions found within introns and exons have at least two possible functions 
based on previously identified binding sites at similar locations in other genomes. CTCF has 
been shown to function as a repressor when bound to introns by blocking RNA polymerase II 
and stalling transcription, such that the full RNA transcript is not completed and thus gene 
expression is repressed. An example of this occurs at the BCL6 locus of the human genome [66]. 
Two CTCF binding sites are located at the 5’ end, one at the 3’ end, and multiple putative CTCF 
binding sites are located within intron 1. The intron 1 putative sites have shown robust 
enrichment for CTCF in H929 cells. These same putative sites show enrichment in Raji cells 
when methylation is removed by treatment with 5-Aza-C. A CTCF knockdown with a ctcf short 
hairpin RNA resulted in an increase of BCL6 expression. By comparing cell types with varying 
levels of methylation at a particular CTCF binding site and analyzing its ability to bind CTCF 
and its effects on BCL6 transcription,  this study was able to demonstrate that CTCF can act as a 
repressor when bound to intronic sequences[66]. Perhaps further study of CTCF binding in 
multiple tissues of An. gambiae, resulting in the identification of variable CTCF binding sites 
across cell types will provide similar opportunities to study CTCF function at introns in this 
species. 
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Other evidence has shown that CTCF bound to the exon of a gene causes it to be 
included in the transcript by pausing RNA polymerase II, then resuming transcription such that 
the bound exon is included in the transcript [65]. This study compared cell types with varying 
expression levels of the splice variants of human CD45. A comparison of published CTCF ChIP-
Seq results revealed variation in CTCF binding at exon 5 of CD45 across the cell types. ChIP 
data revealed that CTCF binding at exon 5 and the inclusion of exon 5 in the transcript were 
shown to be linked. ChIP data also revealed that RNA polymerase II pausing just upstream of 
the CTCF binding site was shown to correspond to CTCF binding and exon 5 inclusion, as well 
as an increase in exon 4/5 and 5/6 junctions in the transcript. RNA Pol II has shown it can 
resume transcription when CTCF is bound at exon 5. These data show that CTCF binding is 
important to the inclusion of exon 5. When the CTCF binding site is methylated, CTCF does not 
bind and RNA polymerase II binding does not occur.  This leads to the exclusion of exon 5, 
evidenced by the loss of exon 4/5 and 5/6 junctions and an increase of 4/6 junctions. Thus CTCF 
has been shown to play a role in distinguishing between splice variants [65]. The potential 
intronic and exonic CTCF binding identified in our data set may lead to an improved 
understanding of gene regulatory mechanisms in An. gambiae. More CTCF ChIP-Seq data from 
other An. gambiae cell types will be necessary to conduct such studies. 
At the HPX 6 locus, a binding site is located upstream of the promoter and appears to be 
a candidate insulator for HPX 6, insulating it from cross talk outside of its transcriptional 
regulatory region. However, this binding site is also located at the promoter of a novel gene and 
appears that it could act as an activator or repressor of this gene. Such an example could be 
studied to determine how CTCF functions when multiple scenarios are possible. If Ohlsson et al. 
(2010) [42] is correct and the underlying sequence determines the function of CTCF, then 
perhaps identification of the sequence at such positions will provide improved predictions of 
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function compared to the position relative to genes. Furthermore, recent work suggests that other 
proteins bound to adjacent DNA sequences forming complexes with CTCF may play a role in 
determining the functional role of CTCF at a given binding site [78]. 
As mentioned above, CTCF function cannot be predicted from relative proximal 
genomic position to genes alone. However, this work provides the necessary data to begin the 
study of the effects of CTCF on important genes and gene clusters. Further study of the function 
of CTCF at these varying types of binding site regions will require individual analysis of each 
CTCF binding site peak. Therefore, our analysis is focused on genes that may be helpful for 
establishing transgenic strategies for controlling the transmission of mosquito borne diseases. As 
such, genes important for immunity, blood feeding, sex differentiation, and development have 
been included in this analysis. 
2.4.3 CTCF may regulate genes important for immunity 
The CLIP genes are serine protease inhibitors that play a role in regulating the 
melanization response, which is a process that encapsulates Plasmodium at the ookinetes stage in 
the midgut of the mosquito. Knockdowns of CLIP genes have shown that some enhance 
melanization while others have been shown to reduce melanization [85]. Four CLIP gene regions 
are proximal to identified CTCF binding site peaks. Two different CLIP gene regions, one 
containing primarily CLIPB genes on Chromosome 2R and the other containing primarily 
CLIPA genes on Chromosome 3L, are each flanked by CTCF binding site peaks. Interestingly, 
two genes in the CLIPB, clipB3 and clipB4 region are necessary for activation of the 
melanization process and two genes in the CLIPA region, clipA2 and clipA5 block melanization 
[85]. In both cases, the flanking positions of the CTCF binding site peaks, relative to the CLIP 
gene clusters, suggest an insulating role for CTCF at these genomic locations based upon results 
in other organisms that indicate that genes and clusters of genes are insulated by flanking 
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insulator sequences, such as the genes of the bithorax complex in D. melanogaster. CTCF may 
play an important regulating role in maintaining an appropriate balance between the expressions 
of these two groups of genes in order to regulate the melanization process. Further understanding 
of this process may be helpful in the development of mosquito strains refractory to disease 
transmission. 
Two other CTCF binding site peak positions near CLIP genes suggest another possible 
function for CTCF. CLIPA8 and CLIPB17 have CTCF binding site peaks within their promoter 
regions, indicating that CTCF may act as a repressor or an activator for these two genes. Also, 
the CTCF binding site peak 4.4kb upstream of CLIP A8 poses an interesting question regarding 
CTCF function when it is bound near two genes and another CTCF binding site. This nearby 
peak may have an insulating influence upon the expression of CLIPA8. However, it is important 
to note that this same CTCF binding site peak is also located within the promoter region of novel 
gene AGAP010728 and may simply function as an activator or repressor of that gene. More 
research needs to be performed to determine how neighboring CTCF binding sites regulate gene 
expression in the same genomic vicinity. 
The other immunity gene of interest is cactus (cact). Identified as a negative regulator of 
the immune response Toll pathway in D. melanogaster, RNA interference-mediated silencing of 
cact results in Toll pathway activation. This has been shown to significantly decrease the P. 
berghei burden, and the removal of the negative regulator can induce an immune response 
without a pathogen challenge [86]. A CTCF binding site peak is located at the cact promoter in 
An. gambiae. It appears that CTCF may play an important role in the regulation of cact 
expression. Downstream of cact, the novel gene, AGAP007941, also has a CTCF binding site 
peak at its 2nd exon. Although its function is unknown, further study could improve the 
understanding of intragenic gene regulation by CTCF. The location of these peaks suggests that 
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CTCF may act as an activator, a repressor, or as an intragenic regulator distinguishing between 
splice variants in An. gambiae. Understanding this relationship may be useful in the development 
of a Plasmodium resistant strain of mosquitoes, as well as an informative model of CTCF 
function. 
2.4.4 Some heme-peroxidase genes may be regulated by CTCF 
CTCF binding site peaks have been identified near several heme-peroxidase genes. As 
stated in Chapter I, the peroxidase gene family is the only gene family that demonstrates a 
significant difference in copy number when comparing An. gambie and D. melanogaster [24]. 
Most of the CTCF binding sites are found flanking heme- peroxidase genes in a relatively small 
genomic region. One is found within the intron of the long splice variant of HPX 4 and upstream 
of the short splice variant. In the malaria mosquito, An. albimanus, peroxidase activity has been 
localized to the posterior lobe of the salivary gland of female mosquitoes just before blood 
feeding [25]. It was also detected in nitrocellulose membranes probed by hungry mosquitoes. 
Peroxidase activities were lower in salivary glands of mosquitoes after probing and blood 
feeding. Thus, it was suggested that in salivary glands, heme-peroxidase functions as an 
antagonist to vasoconstricting substances [25]. The HPX 4 gene is of particular interest given the 
position of the CTCF binding site peak that suggests CTCF may play a role in regulating the 
expression of the two splice variants. The function of these genes in An. gambiae is still 
speculative; however, understanding the role of CTCF in regulating the expression profiles of 
these genes that may be important for blood feeding and pathogen transmission may lead to 
improved transgenic strategies for pathogen transmission control. 
One heme peroxidase gene identified in An. gambiae, HPX 15, known as an 
Immunomodulatory peroxidase (IMPer) has been discovered to assist in the formation of a 
peritrophic matrix with dual oxide (Duox) upon blood feeding in female An. gambiae. The 
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peritrophic matrix forms around the blood bolus in the midgut to prevent contact of blood cells 
and dietary bacteria with the mid gut epithelium, as a first line of defense against pathogens, and 
as a means of allowing dietary bacteria into the midgut without eliciting an immune response. 
IMPer and Duox are secreted from the midgut epithelium and catalyze protein crosslinking in the 
mucin layer to form the peritrophic matrix. The peritrophic matrix has been shown to reduce the 
permeability of immune elicitors against bacteria and plasmodium parasites.  When IMPer is 
silenced via dsRNA, the median number of P. berghei oocysts present 7 days post infection is 
reduced by 9.2 fold. Ookinetes invade the midgut in IMPer silenced individuals; however, they 
are killed and appear fragmented. Silencing of IMPer in An. gambiae and An. Stephensi also 
reduced P. falciparum infection. It was shown that when IMPer is silenced, NOS, an enzyme 
that generates nitrous oxide, which is a potent antiplasmodium effector molecule, is induced. 
Similar results were obtained when Duox was silenced, thus Duox and IMPer are necessary to 
form the peritrophic matrix in the midgut which protects Plasmodium ookinetes. Thus, reducing 
the expression of IMPer (HPX 15) allows for the An. gambiae immune system to protect itself 
from Plasmodium infection via induction of the antiplasmodium molecule, NOS, due to lack of 
formation of the peritrophic matrix [72]. Increased understanding of CTCF’s role in 
transcriptional regulation of HPX15 may provide more insight that would be useful for 
investigating the mosquito immune system as a means to reduce plasmodium transmission. 
2.4.5 CTCF binding site peaks  are located near important sex differentiation genes 
Doublesex is a well conserved protein with a well conserved binding site among 
dipterans, and is responsible for the normal expression of secondary sexual characteristics. A sex 
specific variant binds near genes controlling secondary sexual characteristics to regulate them in 
a sex-specific manner. The percentage (~4%) of doublesex binding motifs identified among the 
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CTCF binding site peak sequences was the same as that identified throughout the entire genome. 
Therefore, there appears to be no correlation between CTCF binding and doublesex binding. 
Two other genes important for sex differentiation are sex lethal (sxl) and msl-2, which 
work in concert to control dosage compensation in D. melanogaster. Little is known about 
dosage compensation in An. gambiae; however, orthologs for these genes exist in An. gambiae 
and an improved understanding of their transcriptional regulation could lead to a better 
understanding of the mechanisms governing sex differentiation and dosage compensation in this 
species. The An. gambiae msl-2 ortholog is located between two CTCF binding site peaks only 
34.8kb apart. Both peaks are found within intergenic sequences suggesting that they may 
insulate the msl-2 gene.  
The ortholog for sxl is flanked by two CTCF binding site peaks, 58.9 kb apart, with an 
additional CTCF binding site peak within intron 1 of the long splice variant and at the promoter 
of the short splice variant. This peak may be involved in regulating the expression levels of the 
two splice variants, under the control of differential methylation of the binding site, as has been 
described in mammalian systems [65]. As for the flanking binding sites, one is within the TTS of 
the novel gene AGAP003897 and the other is within an intron of the novel gene AGAP003901. 
The flanking binding site regions found within the novel genes may be regulating the expression 
of the two respective genes, depending on which sequences they bind, rather than acting as 
insulators for sxl, or they may be functioning as insulators and intragenic expression regulators 
simultaneously. Further study may provide more insight as to how CTCF distinguishes between 
its multiple functions. Given the interconnected function of MSL-2 and SXL, study of the 
transcriptional regulation of these two genes for the purpose of producing all male mosquito 
populations is an attractive field of research for the implementation of SIT. 
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2.4.6 The CTCF binding site profile of the Anopheles gambiae bithorax complex  
The bithorax complex (BX-C) of D. melanogaster has been well studied. Multiple 
insulator sequences binding different insulator proteins are necessary for regulating the 
expression of ultrabithorax (ubx), abdominal A (abd-A), and abdominal B (abd-B) within nine 
different body segments in order to maintain the Drosophila body plan [87]. Interaction of the 
nine different transcriptional regulatory regions is responsible for their normal expression among 
the nine different body segments. CTCF binds to six of the insulator sequences in the BX-C, as 
well as three other locations. Cloned binding sites have been shown to interact with one another; 
however, deletion of the binding sites only partially reduced the ability of insulator elements to 
interact. The regulation of the BX-C does not appear to be one of simple insulation and relief of 
insulation. Its complexity lies in the involvement of other factors, including polycomb group 
proteins. Many other DNA sequences, such as polycomb response elements, promoter targeting 
sequences, and promoter targeting elements, as well as enhancers, initiators and promoters are 
involved. Therefore, a complete understanding of the function of CTCF at the BX-C is yet to be 
elucidated [61]. 
In the An. gambiae ChIP-Seq data, three peaks are located within the bithorax complex 
that appear to be homologous to three of the binding sites identified among the Drosophila 
insulators, Fab-3, Fab-4, and Fab-8. This suggests conservation of the bithorax complex across 
these two species. The other three CTCF bound insulators may also be present in the An. 
gambiae bithorax complex; however, the sensitivity of the ChIP-Seq experiment may not have 
been sufficient to detect them. These binding sites may or may not have the same function as 
their likely homologs in Drosophila.  Further assays, as outlined above, will be necessary to 
determine their function 
 
68 
 
2.4.7 An. gambiae CTCF is associated with a variety of DNA sequence motifs 
 CTCF binding site peak sequences that correlate with CTCF antibody enrichment on 
chromosome bands, and CTCF binding site peak sequences that have been validated using ChIP-
PCR were used to identify four potential CTCF binding site motifs. These four motifs are found 
in 54% of the 212 sequences input into AlignACE. The percentages of motifs 17, 24, 27, and 29 
among the entire CTCF binding site data set were 11.9%, 7.8%, 8.3%, and 8.4%, respectively. 
These low percentages were unexpected given that the primary Drosophila CTCF consensus is 
found among 50% of Drosophila CTCF binding sites identified by ChIP-Seq, and second and 
third motifs were identified among another 40% and <10% of the putative Drosophila CTCF 
binding sites. The total number of CTCF binding site peaks  identified in An. gambiae (2,416) is 
comparable to the total number of CTCF binding sites identified in Drosophila (2,871)[44],both 
using a ChIP-Seq technique. As both species have comparable numbers of genes in their 
respective genomes (13,460 and 17,864) [3, 67, 68, 88], these results suggest a low rate of false 
positives from the ChIP-Seq identification method. The use of CTCF binding site peak 
sequences that correlate with the CTCF immunostained chromosomes or have been validated 
with ChIP-PCR should have eliminated most false positives from the dataset input into 
AlignAce, thus providing the most accurate analysis possible.   
 Van Bortle et al. [44] identified three CTCF binding site motifs based on their ChIP-Seq 
data. The secondary and tertiary motifs were representative of binding sites with lower CTCF 
occupancy and the presence of binding sites for insulators nearby. The variable consensuses 
were believed to be affected by these other insulator binding sites, CP190 being considered the 
most likely due to the necessity of CP190 for CTCF to bind at a subset of its binding sites [44]. 
This may also be the case for An. gambiae; however, the motifs identified with the An. gambiae 
data are not as conserved as those identified for Drosophila. Each of these was only present in 
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11.9% or less of the 2,416 identified CTCF binding site peaks. Therefore, nearby binding sites of 
other insulator proteins does not likely solely explain the high variability of sequences that is 
seen in the An. gambiae ChIP-Seq dataset. CTCF may have been detected at some of the 
identified sequences due to indirect interactions with other bound proteins. However, this would 
also be expected to occur in Drosophila, resulting in a less conserved consensus. Therefore, 
assuming neither of these possibilities are the primary cause for variability among the An. 
gambiae CTCF binding site peak sequences, these results suggest that An. gambiae CTCF binds 
to a wider variety of DNA sequence motifs than Drosophila CTCF.    
Further experiments identifying the binding sites of other insulator proteins, such as 
CP190, and Su(Hw), will provide more insight as to whether or not these proteins are also 
associated with any of the four identified motifs. Chromatin Immunoprecipitation (ChIP) 
Chromosome Conformation Capture (3C) could be used to identify interactions between proteins 
bound by these motifs. ChIP-Seq with three biological replicates with the CTCF antibody can be 
performed, as well as using an alternative An. gambiae CTCF antibody would increase the 
number of high confidence CTCF binding site peak sequences. Electrophoretic Mobility Shift 
Assays will be necessary to identify actual nucleotide sequences bound by CTCF. These 
experiments will aid in identifying candidate insulator sequences to insulate transgenes. 
2.5 Conclusions 
The findings of this study accomplished the goal of identifying a large sample of CTCF 
binding sites throughout the An. gambiae genome, of which a subset can be assayed for insulator 
function and eventually incorporated into a transgene construct to evaluate their effectiveness in 
overcoming position effects in transgenic mosquitoes. In addition to our primary goal, the 
identification of CTCF binding sites throughout the genome reveals some of the genes that may 
be regulated by CTCF. Variable positions of CTCF binding sites in relation to neighboring genes 
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provides insight as to the role CTCF may play in regulating the transcription of these genes. 
Further studies will be necessary to determine the functional role of CTCF at individual genomic 
loci. The model for the diverse functional roles of CTCF put forth by Ohlsson et al. (2010) [42] 
states that the CTCF binding site sequence determines the function of CTCF at a particular 
position[42]. Some binding sites, based on their position, appear as though they could have more 
than one function. Such situations will require functional assays to determine the role of CTCF at 
those loci. The variety of sequence motifs among the CTCF binding site peaks is unexpected. 
This suggests that An. gambiae CTCF binds to a more variable set of DNA sequences than 
observed in Drosophila. Electrophoretic Mobility Shift Assays will need to be performed to 
identify actual nucleotide sequences bound by An. gambiae CTCF. 
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CHAPTER III 
EXPRESSION PROFILES OF THE INSULATOR PROTEINS, CP190 AND SU(HW) in Aedes 
aegypti 
3.1 Introduction 
 CTCF is the only known insulating protein in vertebrate genomes. Dipteran genomes are 
much more compact and have at least five insulator proteins in addition to CTCF: BEAF-32, 
Zw5, Su(Hw), GAGA factor and CP190 [70]. BEAF-32 and Zw5 bind to the scs’ and scs 
insulating elements respectively. Su(Hw) binds to a specific sequence within the gypsy 
transposable element, as well as other sequences throughout the Drosophila genome [73]. 
GAGA factor binds to insulator sequences throughout the Drosophila genome, including 
Frontalabdominal 7 (Fab 7) [89]. CP190 has been shown to have overlapping binding sites with 
other insulator proteins such as CTCF and Su(Hw) throughout the fly genome [52, 90]. CP190 
occupancy has been shown to be responsible for H3 depletion, and CP190/dCTCF double 
occupancy sites have been detected at the borders of H3K27me3 islands, suggesting that it plays 
a role in chromatin remodeling with CTCF [52]. CP190 has been shown to be necessary for 
CTCF binding at some binding sites [90].  
 CTCF and CP190 are important for the regulation of body patterning in development. 
Drosophila studies show that dctcf mutants show a homeotic phenotype and pharate lethality 
[90]. These studies showed that most dCTCF binding sites are also occupied by CP190, 
including insulators within the bithorax complex. The enhancer blocking ability of Fab 8 was 
tested in an enhancer blocking assay using the white enhancer and the mini-white reporter gene. 
All CP190 mutants resulted in increased eye pigmentation, thus revealing the need for CP190 at 
the Fab 8 insulator for proper insulator function [90]. 
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 Su(Hw) has been shown to bind throughout the Drosophila genome at sequences within 
the gypsy retrotransposon, as well as at non-gypsy sequences [73]. These two different sequences 
may reflect different functions for Su(Hw) [11]. Previous immunohistochemistry studies showed 
that CP190 colocalized with Su(Hw); however Su(Hw) did not appear to colocalize at sequences 
bound with CTCF [90]. However, more recent ChIP-Seq data revealed that Su(Hw) and CTCF 
bind at adjacent sequences, within 200 to 300 base pairs, and may be responsible for important 
chromatin architecture and insulator activity at the borders of H3K27 rich regions of the genome. 
The presence of thousands of independent Su(Hw) sites likely biased the earlier analysis to lead 
the authors to believe that CTCF and Su(Hw) did not colocalize [58]. 
 This Drosophila ChIP-Seq analysis of insulator proteins also identified three motifs for 
CTCF binding. The most common, or primary motif was found to generally bind only CTCF. 
However, at the secondary and tertiary motifs, CTCF colocalized with Su(Hw), BEAF-32, 
CP190, MOD(MDG4), and other cofactors at the borders of H3K27 enriched regions. As shown 
at the Fab 8 insulator, CP190 and other insulator proteins may be necessary for insulator 
function at some CTCF binding sites [43]. 
 Putative orthologs for cp190 and su(Hw) exist in Anopheles gambiae and Aedes aegypti. 
According to the An. gambiae expression profile database at UC Irvine (Figure 11) [54, 61, 71, 
78], the expression profile of the cp190 ortholog is similar to that of the Anopheles gambiae ctcf 
ortholog profile across life stages from larvae to 15 days post blood feeding, with time points at 
24 hours post blood feeding, 48 hours post blood feeding, 72 hours post blood feeding, and 96 
hours post blood feeding. Adult male and non-blood fed adult female expression profiles were 
also compared. Although overall expression levels of ctcf are higher than cp190 expression 
levels across all life stages in Anopheles gambiae, the data show that the expression levels of 
both profiles increase with blood feeding and gradually decrease over time. Expression of cp190 
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reaches its peak at 48 hours and ctcf expression reaches its peak at 72 hours. Both patterns 
indicate an important role in embryo development, and are consistent with an interdependent 
function of one another, as is suggested by the previously mentioned Drosophila data [44]. 
A similar expression profile for the Ae. aegypti ctcf ortholog was determined using gel 
based RT-PCR analysis across the life stages from embryo < 1 hour post oviposition to ovaries 
of blood fed females. The life stages and time points examined were < 1hour post oviposition, 24 
hours post oviposition, larvae, female pupae, male pupae, female adult (non-blood fed), male 
adult, ovaries non-blood fed, and ovaries blood fed [50]. The expression profile for ctcf across 
these life stages is similar to that of ctcf and cp190 in Anopheles gambiae. Both embryo stages 
show increased expression levels, with that of ctcf expression at <1 hour post oviposition 
showing the most elevated expression level. Ovaries post blood feeding show a significant 
amount of expression compared to non-blood fed ovaries. These data are consistent with ctcf 
having an important role in development. Considering the Drosophila and An. gambiae data 
regarding ctcf and cp190 expression, as well as the dependence of CTCF binding on CP190 at 
some CTCF binding sites throughout the Drosophila genome, it is likely that the Ae. aegypti 
ortholog to cp190 would have a similar expression profile to the Ae. aegypti ortholog to ctcf. In 
light of the recent ChIP-Seq data suggesting interaction of Su(Hw) with CTCF at secondary and 
tertiary CTCF binding motifs, it would also be likely that Ae. aegypti su(Hw) would have an 
expression profile similar to those of ctcf and cp190. This chapter summarizes expression 
profiles for the Ae. aegypti cp190 and su(Hw) orthologs using RT-PCR across eight life stages 
and an additional three ovarian stages for Aedes aegypti cp190. 
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Figure 11: Expression profiles of An. gambiae cp190 and ctcf. Data from the UC Irvine 
Anopheles gambiae expression profile database [54, 61, 71, 78] shows expression levels for 
cp190 and ctcf across larvae, male, non-blood fed female, 24, 48, 72, 96 hrs., and 15 days post 
blood feeding life stages. 
 
 
3.2 Materials and Methods 
 Total RNA was extracted from embryos 2 to 3 hours post oviposition, embryos 24 hours 
post oviposition, late larval stage, male pupae, female pupae, male adults, non-blood fed female 
adults, female adults post blood feeding, ovaries from non-blood fed females, ovaries from 
females 48 hours post blood feeding, and ovaries from females 72 hours post blood feeding. All 
RNA was extracted using a standard Trizol method. Each sample of RNA was used to synthesize 
cDNA for each life stage from which RNA was extracted using the High Capacity Reverse 
Transcription Kit (Foster City, CA). The cDNA concentration for each sample was measured on 
a Nanodrop spectrophotometer (Nanodrop Technologies, Wilmington, DE). 
 Primers were designed at the 5’ end of the transcript of the Ae. aegypti ortholog for 
cp190 (AAEL002771-RA), flanking a 416 base pair region from nucleotide 1317 to nucleotide 
1732. Primer sequences are as follows Forward: 5’- CCCTTGGCTGTGTCTACGTT-3’, 
Reverse: 5’- ATTCATCGTCCGAGAAATCG-3’. Primers were designed in the middle of the 
CTCF binding site peak Anopheles gambiae cp190 
expression profile 
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transcript of the su(Hw) Ae. aegypti ortholog (AAEL002145-RA), flanking a 308 base pair 
sequence from nucleotide 946 to nucleotide 1235. Primer sequences are as follows: Forward: 5’-
ACTGGTGAACGACCTATCG-3’, Reverse: 5’-CTTCCGGATGAACGACTTTG-3’. Each PCR 
mixture consisted of 100 nanograms of template cDNA, 0.8µl of each primer for a final 
concentration of 0.8µM, and 10µl of 2x Go TAQ master mix in a total volume of 20µl. The PCR 
amplification conditions utilized were as follows: 1: 95oC for 5 minutes, 2: 95oC for 15 seconds, 
3: 52oC  (cp190) and 51oC (su(Hw) for 15 seconds, 4: 72oC for 30 seconds, 5: repeat steps two 
through four 29 times for a total of 30 cycles, 6: 72oC for 2 minutes. PCR products were 
separated on a 1.5% electrophoresis gel at 100 volts at 45 mAmps for 30 minutes. Each 
experiment was performed twice giving the same results. 
3.3 Results 
 Expression of the Ae. aegypti cp190 ortholog (AAEL011409) (Figure 12) was observed 
across seven of the eight life stages examined. Amplification was not observed for the male adult 
template. Of the ovarian tissue examined, amplification was not observed for the non-blood fed 
samples. The lack of amplification of for these two life stages is likely due to low levels of gene 
expression. Both blood fed samples at 48 hours post blood feeding and 72 hours post blood 
feeding resulted in amplification products, revealing expression of cp190 in these tissues. β-actin 
expression was used as a control across eight of the life stages, from embryo 2 to 3 hours post 
oviposition to female adult blood fed.  Expression of β-actin was consistent across 5 of the life 
stages from late larva to non-blood fed female adult. Lower expression of β-actin was observed 
in the embryonic stages. This may be explained as they are developmental stages in which β-
actin would be expected to have low expression levels due to the lack of muscle development at 
these stages. A slight decrease in β-actin expression in the blood fed female sample may be 
explained by lethargy in the females after a blood meal. Amplification products of the cp190 
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ortholog observed at 2 to 3 hours post oviposition, female adult post blood feeding, ovaries 48 
hours post blood feeding, and 72 hours post blood feeding, were at higher levels compared to 
those of the remaining life stages, mirroring the Aedes aegypti ctcf ortholog expression profile. 
Ovaries 72 hours post blood feeding and the embryos 2 to 3 hours post oviposition were the 
stages at which cp190 appeared to be most highly expressed. These results are consistent with 
cp190 playing an important role in embryo development.  
Expression of Ae. aegypti su(Hw) (Figure 12) was observed across all eight life stages. 
The embryo 2 to 3 hours post oviposition and female blood fed templates showed a significantly 
higher expression level compared to all other life stages. All remaining life stages showed a 
minimal amount of expression. These data mirror the Ae. aegypti ctcf and cp190 expression 
profiles, as well as the An. gambiae expression profiles for the same orthologs. These data are 
consistent with the notion that Su(Hw), CTCF, and CP190 may interact at some binding 
sequences, as is suggested by the recent Drosophila ChIP-Seq data [44]. 
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Figure 12: Expression profiles of Ae. aegypti cp190 and su(Hw). RT-PCR amplification of 
cDNA fragments of Ae. aegypti orthologs for cp190, su(Hw), and β-actin (control) across the 
following life stages: embryo 2-3 hrs. post oviposition (E2-3), embryo 24 hrs. post oviposition 
(E24), late larvae (LL), male pupae (MP), female pupae (FP), male adult (MA), female adult 
(FA), female blood fed (FBF), ovaries non-blood fed (ov NBF), ovaries 48 hrs. post blood 
feeding (ov 48), ovaries 72 hrs. post blood feeding (ov 72) and negative no template control (-
ve). 
 
3.4 Discussion 
The expression profiles of the Ae. aegypti orthologs of cp190 and su(Hw) were 
visualized across eight life stages, as well as blood fed and non-blood fed ovary tissue for cp190. 
This work has revealed that Aedes aegypti cp190 is highly expressed in the early embryo, blood 
fed ovaries, and blood fed whole animal adult female compared to the other life stages assayed. 
This profile mirrors the expression profile of the An. gambiae ortholog for cp190, suggesting that 
its expression throughout the life cycle is conserved across these mosquito species. This profile 
also mirrors the expression profile of the Ae. aegypti ortholog for ctcf. The correlation of 
expression profiles suggests that CTCF and CP190 may have similar interdependent functions as 
has been shown in Drosophila [44]. 
Anopheles gambiae ctcf expression profile 
Aedes aegypti cp190 expression profile 
               E2-3        E24        LL        MP          FP         MA       FA        FBF        ov         
                         
                                                                                                                                      
             
Aedes aegypti su(Hw) expression profile 
 E2-3        E24           LL          MP           FP            MA        FA           FBF           -ve  
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 The Ae. aegypti ortholog of su(Hw) was also shown to have a similar expression profile 
to cp190 and ctcf in both mosquito species. Given the increased expression levels of these genes 
in early embryo and blood fed ovaries above all other life stages observed, it appears that the 
products of these genes may play important roles of gene regulation at developmental life stages. 
These data are also consistent with the Drosophila ChIP-Seq insulator protein data which show 
that in Drosophila, these proteins colocalize at a subset of insulator sequences binding to a 
secondary or tertiary CTCF binding motif. Many of these motifs are located at the borders of 
H3K27 enriched regions and CTCF has been shown to be necessary for maintaining these 
regions [44]. CP190 has also been shown to be necessary for the enhancer blocking function of 
CTCF at Fab 8 [90]. Therefore, the interaction of multiple insulator proteins may be necessary 
for proper chromatin organization and insulator activity at some CTCF binding sites. 
3.5 Conclusions 
 The expression profiles of the Ae. aegypti orthologs of cp190 and su(Hw) mirror the Ae. 
aegypti expression profile for the ctcf ortholog and the expression profiles for the An. gambiae 
orthologs for ctcf and cp190. These data indicate that cp190 is likely to be important for 
development based on its increased expression levels in embryos, blood fed females, and blood 
fed ovaries compared to all other life stages assayed. The Aedes aegypti ortholog of su(Hw) had 
a similar expression profile suggesting that it is also likely to be important for development. The 
parallel expression profiles across life stages with ctcf suggest that CP190 may have a similar 
role in facilitating binding of CTCF to its binding site sequences, based on data from 
experiments with D. melanogaster in which it was shown that CP190 was necessary for CTCF 
binding to a subset of its binding sites [90]. These data are also consistent with recent ChIP-Seq 
data for the Drosophila insulator proteins CP190, CTCF, and Su(Hw), which show that all three 
bind within 200-300 base pairs of one another at secondary and tertiary CTCF binding motifs, 
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along with the Drosophila specific insulator protein BEAF-32 [44]. It has been suggested that 
these proteins act synergistically to maintain chromatin architecture and insulator activity [44]. 
This may also be the case in mosquitoes. Further experiments will be necessary to identify 
spatial and functional relationships between CP190, Su(Hw), and CTCF in mosquitoes. ChIP-
Seq experiments with antibodies raised against the mosquito orthologs to CP190 and Su(Hw) 
need to be performed to identify any colocalization of the three proteins within the genomes. 
Also, RNAi knock downs of each of these three insulator proteins would be useful in identifying 
any lack of dependence of these three proteins, for DNA binding at any of the identified binding 
sites. For the primary purpose of identifying optimal sequences for insulating transgenes in order 
to minimize position effects, sequences with multiple bound insulator proteins could be 
compared with sequences with single bound insulator proteins in an enhancer blocking assay. 
The sequences identified as the most effective enhancer blockers could be empirically tested in 
transegenic experiments with whole mosquitoes. 
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CHAPTER IV 
CONCLUSION AND FUTURE DIRECTIONS 
 CTCF has been well studied in vertebrates and Drosophila over the past two decades 
[41]. These studies have provided much insight regarding the potential functional roles of CTCF 
in mosquito genomes since the discovery of its ortholog in An. gambiae and Ae. aegypti [49]. 
CTCF’s potential role as an insulator protein could enable the identification of insulator 
sequences that could be used for improving mosquito transgenesis techniques. Furthermore, its 
likely role as a genome organizer has also provided the impetus for this work to identify regions 
of CTCF binding in the An. gambiae genome. Not only does the multitude of high resolution 
CTCF binding regions identified in this study provide potential insulator sequences that can be 
tested for potential use in the improvement of mosquito transgenesis, it also provides a new 
model organism for the study of CTCF function. Armed with the knowledge of the genomic 
locations of CTCF binding in An. gambiae, scientists can study CTCF in a species that is 
relatively closely related to Drosophila that has a different chromatin structure. Furthermore, the 
identification of CTCF binding sites in related Anopheline species that have undergone recent 
speciation events will provide insight into the role of chromatin organization in this process. This 
will lead to further insight regarding the evolution of chromatin organization. 
 Analysis of the CTCF ChIP-Seq data revealed that some of the chromosome bands on 
the CTCF immunostained chromosome spreads correlated with the identified CTCF binding site 
peaks.  Analysis of these CTCF binding site peaks and those that were validated by ChIP-PCR 
identified four motifs. These four motifs represent a small percentage of the total number of 
identified CTCF binding site peaks. This was unexpected considering that the consensuses 
discovered for Drosophila CTCF represented nearly 100% of the identified sequences. This 
leads to the conclusion that An. gambiae CTCF binds to a wider variety of sequence motifs 
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throughout its genome. Further experiments will be necessary, including EMSA, to identify 
which sequences bind to CTCF. 
 This study only scratches the surface of potential future advances in mosquito 
transgenesis and improving our understanding of chromatin organization, as well as the role 
insulator proteins play in gene regulation. The multiple genomic positions of CTCF binding site 
peaks in relation to genes and one another provide opportunities to study gene regulation and 
chromatin organization in this species. One of the deficiencies of the approach taken to date is 
the lack of insight regarding CTCF long range interactions. Chromatin Immunoprecipitation 
(ChIP) Chromosome Conformation Capture (3C) analysis would provide an extra dimension to 
the knowledge this study has provided. In addition to the identification of CTCF binding regions, 
Su(Hw) and CP190 were shown to have similar expression profiles with CTCF across multiple 
life stages for Ae. aegypti, similar to the comparison of the expression profile data between 
CTCF and CP190 from the UC Irvine An. gambiae gene expression database [54, 61, 71, 78]. 
These data are consistent with the notion that insulator proteins bind adjacent to one another at 
some genomic locations, as has been shown in Drosophila [44], implying a cooperative role in 
regulating gene expression. 
 With regard to using CTCF binding site peak sequences to improve mosquito 
transgenesis, an enhancer blocking assay performed in cultured cells, similar to that performed 
by Li et al. [83] in S2 cells, would narrow down the candidate pool of potential sequences that 
may be used to flank a transgene to improve its expression. The candidate sequences with the 
most consistent and effective rates of enhancer blocking would be incorporated into a transgene 
construct flanking the transgene and any associated regulatory sequences.  To test the 
effectiveness of the insulator sequences, insulated and uninsulated transgenes would be 
integrated into the embryonic germ line at the same chromosomal locations using the ΦC31 
82 
 
integrase system [18] to ensure that transgene expression is evaluated within the same chromatin 
environment [39]. Effective insulator sequences could be used to create a strain of mosquitoes 
with insulated attP docking sites throughout the genome by randomly integrating attP sites 
flanked with insulator sequences. This would provide researchers with a strain of mosquitoes 
into which any effector or reporter transgene would be flanked by insulators when integrating 
transgenes with the ΦC31 integrase system. Figure 13 illustrates how an insulated attP site 
would be used to insulate a site specifically integrated transgene flanked with attB sites using the 
ΦC31 integrase system. 
 
 
 
 
A)                                                                    B)          Donor Plasmid 
Chromosome    Ins.      attP       Ins.   Chromosome 
 
 
                                                                                      attB                                             attB 
 
                                                                                                        
                                                                                               
                                                                                                              transgene 
C) 
 
 Chromosome    Ins.    attR       transgene        attL       Ins.   Chromosome 
 
   
 
Figure 13: Diagram of an insulated attP site.  A) An attP docking site randomly integrated 
into the genome with flanking insulator sequences (Ins.). B) A donor plasmid containing a 
transgene flanked by attB sites. C) The integrated transgene flanked by attR and attL sequences, 
formed by the recombination of the attP and attB sites, and the insulator sequences. 
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The distribution of CTCF binding sites identified in this work suggests multiple roles for 
CTCF throughout the genome. Many of the intergenic binding locations suggest a role as an 
insulator, while the CTCF binding site peaks found within promoter regions suggest that it may 
be acting as an activator or a repressor at these genomic locations. Also, a number of CTCF 
binding site peaks are within introns and exons suggesting an intragenic regulatory role. 
Individual functional assays will be necessary to identify the likely function of CTCF at specific 
genomic locations. Activation and repression activities can be assayed by inserting CTCF 
binding sequences proximal to reporter genes that will be transfected and incorporated into the 
chromosomes of either cultured cells or whole animals [79, 80]. Insulator assays similar to the 
one designed by Li et al. [83] can be used to determine enhancer-blocking function. Intragenic 
regulation could be tested by comparing gene expression in cells with differential CTCF binding 
patterns at the binding site peak in question. Importantly, CTCF binding site peak sequences can 
be inserted into multiple types of chromatin environments using the ΦC31 integrase system to 
determine how the different chromatin contexts affect CTCF binding and ultimately CTCF 
function [84].  
In Drosophila, CTCF, CP190, and Su(Hw) have been shown to have cell-type specific 
distributions throughout the genome [70]. These differences in insulator binding may be 
responsible for tissue specific gene expression. As suggested by the data in the current study and 
experiments in other organisms [65, 66], the expression of splice variants may be regulated by 
differential patterns of CTCF binding. To investigate this possibility, it would be necessary to 
perform ChIP-Seq for CTCF in multiple tissues. The neonate larval cells used in the current 
study provide a snapshot sample of CTCF throughout the genome, and there is some data that 
indicates that CTCF binding is conserved between the ChIP-Seq data from the neonate larval cell 
line and the immunostained ovarian nurse cell chromosomes. However, in order to identify cell-
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type specific CTCF binding sites, more tissues will need to be assayed. Ovarian nurse cells are a 
likely candidate due to their importance in development and their increased expression level of 
CTCF in blood fed ovaries above other life stages [50]. The salivary glands and midgut would be 
a good choice due to their role in pathogen transmission. An understanding of how CTCF 
functions in these tissues will lead to a better understanding of the regulation of genes that may 
be useful for preventing pathogen transmission. 
Comparisons of expression profiles of the insulator proteins CTCF and CP190 [54, 61, 
71, 78] in An. gambiae showed similar patterns across nine life stages from larva through six life 
stages post blood feeding. In Ae. aegypti, gel based RT-PCR expression profiles from early 
embryo through blood fed females for Su(Hw), and through two stages of post blood fed ovarian 
tissue for CTCF [50] and CP190, showed increased levels of expression for early embryo, blood 
fed female and blood fed ovaries above all other life stages assayed. This data is consistent with 
the notion that CTCF colocalizes with CP190 and Su(Hw) at a subset of binding sites as is the 
case in Drosophila [44]. This being the case, further work can be performed to identify optimal 
insulator sequences that may contain binding sites for multiple insulator proteins. ChIP-Seq can 
be performed for CTCF in Ae. aegypti to identify insulator sequences in this species, and ChIP 
using antibodies for An. gambiae CP190 and Su(Hw) could be performed in both species, 
followed either by PCR with primers flanking a subset of the identified CTCF binding site peaks, 
or by performing Illumina parallel sequencing with the chromatin immunoprecipitated DNA to 
identify colocalization among the three insulator proteins. It would be interesting to identify 
sequences bound by one, two, and all three of the insulator proteins, and test them for insulator 
function using the assays outlined above to evaluate whether one or two of the three proteins, or 
a combination of all three bind to a sequence producing a more effective insulator than other 
potential insulator sequences. Ultimately, this work will be useful in identifying an ideal 
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insulator sequence that could flank an attP docking site and be used to create a mosquito strain 
ideal for mosquito transgenesis. Additionally, it will further understanding of the roles and 
interactions CTCF has in managing genome wide chromatin architecture and regulating gene 
expression. 
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APPENDIX 
SUPPLEMENTARY DATA 
A-1 
MACS parameters 
ARGUMENTS 
LIST: 
      band width = 200 
      ChIP-Seq file = /galaxy/main_pool/pool5/files/003/628/dataset_3628209.dat 
control file = /galaxy/main_pool/pool5/files/003/627/dataset_3627165.dat 
d = 46 
       effective genome size = 2.60e+08 
    format = BAM 
      model fold = 13 
      name = MACS_in_Galaxy 
     pvalue cutoff = 1.00e-05 
     Ranges for calculating regional lambda are : peak_region,1000,5000,10000 
tag size = 36 
      This file is generated by MACS 
    total tags in control: 29669847 
    total tags in treatment: 2245360 
    unique tags in control: 23661990 
    unique tags in treatment: 1159423 
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A-2 
CTCF binding site peaks near genes of interest 
 
*=validated with ChIP-PCR 
Peak 
ID 
Start  End  # 
tags 
Fold 
Enrich-
ment 
P-value 
1x10^ 
Annotation De-
tailed 
Anno-
tation 
Dis-
tance 
to 
TSS 
 
Nearest 
Promoter 
ID 
 
Descrip- 
tion of genes 
of interest 
3L_ 
301 33239277 33239404 11 19.15 -7.544 
promoter-
TSS 
(AGAP0117
79-RA) NA 67 
AGAP011
779-RA 
CLIPA5 
cluster 
*3L_ 
302 33328699 33328803 6 12.39 -5.314 
promoter-
TSS 
(AGAP0117
98-RA) NA -447 
AGAP011
798-RA 
CLIPA5 
cluster 
*2R_ 
254 34439881 34440012 9 13.7 -6.484 Intergenic NA 
-
10520 
AGAP003
244-RA 
ClipB3(8 Clip 
genes) 
2R_ 
255 34499771 34499895 6 16.53 -5.198 
TTS 
(AGAP0032
59-RB) NA 985 
AGAP003
258-RA 
ClipB3(8 Clip 
genes) 
*3L_ 
156 9015497 9015605 6 19.5 -5.623 
promoter-
TSS 
(AGAP0107
31-RA) NA 32 
AGAP010
731-RA CLIPA8 
2R_ 
75 7278745 7278901 34 17.93 -18.599 
promoter-
TSS 
(AGAP0016
48-RA) NA 51 
AGAP001
648-RA CLIPB17 
*3R_ 
30 3214284 3214400 6 11.04 -5.086 
promoter-
TSS 
(AGAP0079
37-RA) NA -106 
AGAP007
938-RA CACT 
*3R_ 
31 3228650 3228758 7 16.93 -6.115 
exon 
(AGAP0079
41-RA) 
 exon 
2 of 8 349 
AGAP007
941-RA 
CACT 
& 
AGAP007941 
2R_ 
380 48912076 48912207 7 17.87 -6.179 
intron 
(AGAP0040
52-RA) 
 
intron 
1 of 5 35728 
AGAP004
052-RA 
dblsx 
AGAP004050 
2R_ 
379 48627045 48627123 9 16.9 -6.484 
promoter-
TSS 
(AGAP0040
47-RA) NA 34 
AGAP004
047-RA 
dblsx 
AGAP004050 
X_61 9532791 9532909 6 24.37 -5.83 Intergenic NA 5938 
AGAP013
283-RA msl-2 
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A-2 continued 
 
*=validated with ChIP-PCR 
 
Peak 
ID Start  End  
# 
tags 
Fold 
Enrich-
ment 
P-value 
1x10^ Annotation 
De-
tailed 
Anno-
tation 
Dis-
tance 
to 
TSS 
 
Nearest 
Promoter 
ID 
 
Descrip- 
tion of genes 
of interest 
X_62 9567412 9567541 6 21.54 -5.232 Intergenic NA 12321 
AGAP0005
34-RB msl-2 
2R_ 
336 45747249 
4574738
4 6 16.05 -5.089 
intron 
(AGAP0039
01-RA) 
 
intron 
2 of 
10) 5809 
AGAP0039
01-RA  sxl 
*2R_ 
335 45716399 
4571651
9 8 13.28 -5.145 
promoter-
TSS 
(AGAP0038
99-RA) NA 671 
AGAP0038
99-RB sxl  
2R_ 
334 45688191 
4568831
1 16 78 -22.94 
TTS 
(AGAP0038
97-RA) NA 2140 
AGAP0038
97-RA sxl 
*2R_ 
521 60012716 
6001282
2 6 14.62 -6.002 Intergenic NA 
-
91094 
AGAP0046
60-RB BC-X  
2R_ 
522 60297839 
6029796
2 7 24.37 -6.553 
TTS 
(AGAP0046
63-RA) NA 344 
AGAP0046
63-RA BC-X 
2R_ 
523 60312345 
6031247
5 9 8.04 -5.221 Intergenic NA 14854 
AGAP0046
63-RA BC-X 
2R_ 
524 60405670 
6040583
8 6 18.02 -5.314 Intergenic NA 16512 
AGAP0046
64-RA BC-X 
*2R_ 
525 60597396 
6059750
6 6 19.5 -5.579 Intergenic NA 
-
89531 
AGAP0046
65-RA BC-X  
3R_ 
347 42680969 
4268110
6 7 18.63 -8.097 Intergenic NA -4227 
AGAP0097
69-RA GPR-CAL1 
3R_ 
348 42700001 
4270008
3 15 12.23 -8.212 Intergenic NA -6579 
AGAP0097
70-RA GPR-CAL1 
*2L_ 
330 44476004 
4447615
7 7 24.37 -6.175 
intron 
(AGAP0072
37-RA) 
 
intron 
1 of 8 4728 
AGAP0072
37-RA HPX 4 
*3L_ 
182 
12724084 
1272420
1 8 22.18 67.45 Intergenic NA -8799 
AGAP0108
95-RA HPX 10,11 
3L_ 
161 10914598 
1091470
1 65 8.97 -18.841 Intergenic NA 5738 
AGAP0108
11-RA HPX 15,14 
3R_ 
168 
24362783 2436291
4 
6 14.52 -5.785 TTS 
(AGAP0090
33-RA) 
NA 2167  
AGAP0090
33-RA 
 
 
HPX 2 
*2L_ 
331 
44505634 4450576
3 
8 18.84 -5.778 exon 
(AGAP0072
38-RA) 
 exon 
2 of 2 
1033  
AGAP0072
38-RA 
 
 
HPX 4 
*3L_ 
183 
12860633 1286074
9 
6 18.43 -5.314 Intergenic NA -1749 AGAP0109
09-RA 
 
HPX 10,11 
3L_ 
160 
10576666 1057675
1 
14 19.83 -8.51 intron 
(AGAP0108
00-RA) 
 
intron 
4 of 4 
6779  
AGAP0108
00-RA 
 
 
HPX 15,14 
 
